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Abstract: New approaches to the synthesis of 4,7-dichloro-1,10-phenanthrolines and their 
corresponding 9H-carbazol-9-yl-, 10H-phenothiazin-10-yl- and pyrrolidin-1-yl derivatives were 
developed. Their properties have been characterized by a combination of several techniques: MS, 
HRMS, GC-MS, electronic absorption spectroscopy and multinuclear NMR in both solution and 
solid state including 15N CP/MAS NMR. The structures of 5-fluoro-2,9-dimethyl-4,7-di(pyrrolidin-
1-yl)-1,10-phenanthroline (5d), 4,7-di(9H-carbazol-9-yl)-9-oxo-9,10-dihydro-1,10-phenanthroline-5-
carbonitrile (6a) and 4,7-di(10H-phenothiazin-10-yl)-1,10-phenanthroline-5-carbonitrile (6b) were 
determined by single-crystal X-ray diffraction measurements. The nucleophilic substitutions of 
hydrogen followed by oxidation produced compounds 6a and 6b. The electrochemical properties 
of selected 1,10-phenanthrolines were investigated using cyclic voltammetry and compared with 
commercially available reference 1,10-phenanthrolin-5-amine (5l). The spatial distribution of 
frontier molecular orbitals of the selected compounds has been calculated by density functional 
theory (DFT). It was shown that potentials of reduction and oxidation were in consistence with the 
level of HOMO and LUMO energies. 
Keywords: phenanthroline; amination; cyclic voltammetry; 15N-NMR; cyclization; heterocyclic; DFt; 
oxidative nucleophilic substitutions of hydrogen 
 
1. Introduction 
1,10-Phenanthrolines are well known bidentate nitrogen ligands used in coordination chemistry 
for the analysis of transition metal ions and homogenous catalysis [1–4]. Their coordination abilities 
are the result of the contribution of lone pairs of electrons on both nitrogen atoms in the characteristic 
shape of heterotricyclic systems. They have been found applications in supramolecular chemistry, 
luminescent sensors, and photosensitizers for solar cells [5–15]. 1,10-Phenanthrolines have also 
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received much attention as potential targets for anticancer drug development [16–21]. Mainly there 
are two methods for the synthesis of compounds containing 1,10-phenanthroline core. The first one 
is the classical Skraup and Friedlander transformations. The second method is used in the synthesis 
of 4,7-dichloro-1,10-phenanthroline derivatives through the condensation of Meldrum’s acid, 
orthoesters, and ortho-phenylenediamine derivatives, followed by sequential thermal cyclization, 
decarboxylation and treatment with refluxing phosphoryl chloride [22,23]. The synthesis of 4,7-
dichloro-1,10-phenanthrolines offered a possibility of further transformation through replacing 
halogen atoms in C4 and C7 positions. In the literature there are few methods describing their 
modification into amino derivatives [24,25]. In this paper, we report new approaches to the synthesis 
of the aforementioned compounds with in-depth spectroscopic and electrochemical characterization. 
In order to improve the understanding of the chemical behavior of novel 4,7-dichloro-1,10-
phenanthrolines and their amino derivatives, a 15N CP/MAS NMR technique was employed to 
differentiate and characterize the nitrogen atoms presented in their structures, and to show the 
influence of substituents on their chemical shifts. Additionally, computation and X-ray studies have 
been carried out of on the novel 4,7-disubstituted-1,10-phenanthrolines. The investigation of the 
electrochemical properties of these newly designed compounds may provide a promising tool to 
demonstrate their stability towards oxidative and reductive conditions for applications, such as 
advanced synthesis and catalysis. 
2. Results 
2.1. Synthesis of 4,7-dichloro-1,10-phenanthrolines 
In the current study, the functionalization of selected 1,10-phenanthroline derivatives at R, R1 
and R2 positions was the focus, which have not been fully exploited and may serve as interesting 
building blocks. The classical Skraup-Doebner-Miller reaction offers the simplest and fastest 
transformation. To prepare 1,10-phenanthrolines we first attempted to adopt a one-step Skraup-
Doebner-Miller cyclocondensation of ortho-phenylenediamines 1 with unsaturated carbonyl 
compounds. However, like in previous work by other authors, this procedure failed, possibly due to 
an intermolecular condensation [26]. Instead, the synthesis of 4,7-dichloro-1,10-phenanthroline 
derivatives 4 has been carried out using a three-step condensation of 2,2-dimethyl-1,3-dioxane-4,6-
dione (Meldrum’s acid), orthoesters, and ortho-phenylenediamines 1 (Scheme 1) [22,23]. Compounds 
4 were prepared with high yield, even on the scale of several grams. The first yield-determining step 
depends on the double nucleophilic addition of ortho-phenylenediamines (1) to the vinyl group of an 
intermediate obtained from the condensation of Meldrum’s acid and an orthoester (Scheme 2). 
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Scheme 1. Synthesis route of compounds 4 and 5. 
 
Scheme 2. Synthesis route of the compounds 3. R = Me, Et. R1 = H, F, Cl, Br, Me, CN. 
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Anilines are poor N-nucleophiles. Their reactivity strongly depends on the solvents used, and 
substituents in their structures. In a series of experiments it was noticed that a higher isolation yield 
(up to 94%) was obtained for molecule 2d which possesses a methyl group as R1 substituent and 
hydrogen atoms as R (Scheme 2). Replacing the methyl group by a halogen atom (F, Cl, Br) or an 
electron-withdrawing group like CN or COOH in aniline decreases the isolated yield. Additionally, 
it is observed that the yield of products was dependent on the orthoester used. The use of trimethyl 
orthoformate produced the highest yields of compounds 2a, 2b, 2c, 2d and 2g, followed by a lower 
yield using triethyl orthoacetate, and the lowest was triethyl orthoformate of molecules 2f, 2h, 2i, 2j 
and 2l. This reactivity could be explained by increased steric interactions between Meldrum’s acid 
and the orthoesters, which hampers the transformation (Scheme 2). In the syntheses of heterocycles 
2, appropriate esters were produced depending on the ortho esters used as reactants. The hydrogen 
atom in carboxyl group was replaced by methyl or ethyl fragment giving the compounds 2m and 2n, 
respectively. It is of importance that the synthesis of products 2 was accompanied by side reactions 
which led to benzo[d]imidazole type molecules, for example during the synthesis of compound 2f 
1H-benzo[d]imidazole-6-carboxylic acid was isolated. During the next step, diketene was generated 
in situ from molecule 2. This process relies on a thermally induced decarboxylation and acetone 
elimination. Highly reactive ketene underwent a cyclocondensation with the aryl substituent leading 
to compound 3 (Scheme 2). It is noticed that the rate of this reaction was not very sensitive to the 
presence of substituents at the C5 position (R1). This method is suitable for a variety of useful 
functional groups, including ester, CN, alkyl substituents and halogen atoms, with the exception 
however of COOH, which reacted with electrophilic ketene through disturbing cyclocondensation to 
give very complicated reaction mixture. Carbonyl groups at C4 and C7 positions in heterocycle 3 can 
be replaced by chlorine atoms to prepare 4,7-dichloro-1,10-phenanthrolines 4. In a series of 
experiments, molecule 3 was treated with phosphoryl chloride giving quantitatively products 4 
(Scheme 1) [22,23]. 4,7-Dichloro-1,10-phenanthrolines were obtained in high yields (ca. 68–93%) with 
the exception of compounds 4e (48%), 4l (32%) and 4m (38%). The lower yields of these molecules 
could be explained by the hydrolysis of their R1 substituents, i.e., the CN, COOMe and COOEt groups 
and formation of carboxylic acid groups [27]. To avoid the hydrolysis of CN and COOAlk groups, 
and a reverse reaction of the 4,7-dichloro-1,10-phenanthrolines 4 to form the 1,10-dihydro-1,10-
phenanthroline-4,7-diones 3, the excess of phosphoryl chloride should be evaporated under reduced 
pressure. This strategy should facilitate hydrolysis of the excess of phosphoryl chloride. It is noticed 
that the use of basic solutions during the hydrolysis procedure causes the competitive reversion of 
product 4 to molecule 3. Hydroxide ion can substitute for chloride atom at the C4/C7 positions. 
Surprisingly during the isolation of compound 4e an unexpected product 4f was obtained, which is 
explained as a hydrolysis of the heterocycle 4e. It is worth noting that during this chemical 
transformation 4,7-dichloro-1,10-phenanthroline-5-carboxylic acid was not isolated or identified 
(Scheme 3). 
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Scheme 3. Complexity of the hydrolysis reactions of the CN group. 
2.2. Synthesis of 4,7-diamino-1,10-phenanthrolines 
The introduction of substituents R2, such as a chlorine atom in the 1,10-phenanthroline skeleton, 
opened opportunities for the further functionalization. Five 4,7-dipyrrolidinyl-1,10-phenanthrolines 
5 with four novel structures were synthesized from heterocycles 4 by microwave-assisted 
nucleophilic aromatic substitution with a 10-fold excess of pyrrolidine. The nitrogen R2 substituents 
should increase the electron density on nitrogen atoms in 1,10-phenanthrolines (Scheme 1) [24]. 
Reactions were carried out in a sealed vial in a microwave reactor at 130 °C (Scheme 1). MW 
irradiation improves the reactivity of the substitutions, shortening the reaction time to give the 
substitution products in better yields. In the absence of MW irradiation, the substitution reaction 
failed to initiate. The yields of products depend on the substituent R1, which may influence the 
outcome of the reaction through steric and/or electronic effect. Unexpectedly R1 fluorine or chlorine 
atoms failed to undergo substitution. This phenomenon can be explained by a steric hindrance 
attributed to the already introduced pyrrolidinyl rings and too high an electron density on the carbon 
atom at C5 position. Substituents R2 in the pyridine rings in 1,10-phenanthrolines 4 tended to undergo 
more SNAr type substitutions due to the presence of nitrogen atoms which are able to accommodate 
a negative charge in the intermediate state. 
Four 4,7-di(9H-carbazol-9-yl)-1,10-phenanthrolines (5f, 5g, 5h and 5m) and four 4,7-di(10H-
phenothiazin-10-yl)-1,10-phenanthroline derivatives (5i, 5j, 5k and 5n) with seven novel structures 
were synthesized from molecules 4 by nucleophilic aromatic substitution with 9H-carbazole and 10H-
phenothiazine, respectively (Scheme 1). Reagents were stirred for sixteen hours under reflux. The 
chemistry was based on inexpensive, commercially available reagents and easily synthesized 
heterocycles 4 which possess methyl, CN, fluorine or hydrogen atom as R1. The yields of 9H-carbazole 
derivatives 5 were lower than for 10H-phenothiazine derivatives. In all cases the purification of 9H-
carbazole derivatives 5 required chromatographic methods to receive pure products. However, the 
purification of 10H-phenothiazine could be carried out by crystallization from the mixture of CH2Cl2 
(or THF) and hexane to afford products even on a multigram scale. The highest yield and less 
complex reaction mixture of 10H-phenothiazine derivatives can be attributed to the better 
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nucleophilic properties of 10H-phenothiazine anion than 9H-carbazole. Wu et al. obtained the X-ray 
structure of 4,7-di(10H-phenoxazin-10-yl)-1,10-phenanthroline [28], which was cocrystallized with 
THF as a guest molecule located in the crystalline frameworks. The THF molecule is surrounded by 
two 10H-phenoxazine rings and 1,10-phenanthroline core. 1H-NMR and 13C-NMR studies showed 
that the presence of signals from THF for 10H-phenothiazine derivatives 5i, 5j and 5n (Supporting 
Information). It is worth noting that in the case of molecule 5k, with a methyl group as R1, no residual 
THF signals have been detected. 9H-Carbazole derivatives have shown similar supramolecular 
inclusion processes to compounds 5i, 5j and 5n, in which the solvent is located in a cage made by 
1,10-phenanthroline derivatives, however, with smaller intensity. 
Yields of selected 1,10-phenanthrolines 4 and 5 are summarized in Scheme 1. 4,7-Di(10H-
phenothiazin-10-yl)-1,10-phenanthroline derivatives were obtained with yields in the range 84-96%. 
4,7-Disubstituted-1,10-phenanthrolines with a carboxylic acid group as R1 substituent should be 
readily soluble in waters. These bifunctional compounds should mimic amino acids or nicotinic acid. 
Therefore, in order to synthesize appropriate carboxylic acids we carried out the hydrolysis of the 
CN group in molecule 4e, using an excess of acid (ca. 50.0 equiv. HCl) or excess of base (ca. 50.0 equiv. 
NaOH) in the case of 4,7-di(9H-carbazol-9-yl)-1,10-phenanthroline-5-carbonitrile (5m) and 4,7-
di(10H-phenothiazin-10-yl)-1,10-phenanthroline-5-carbonitrile (5n) under the applied conditions. It 
is shown in Scheme 3 that in both cases the reactions does not lead to the formation of the expected 
4,7-dichloro-1,10-phenanthroline-5-carboxylic acid or related molecules as was observed for the 
synthesis of 1,10-phenanthroline-2-carboxylic acid [27]. We isolated unexpected product 4f. The 
hydrolysis of heterocycles 5m and 5n lead to other surprising compounds, namely 4,7-di(9H-
carbazol-9-yl)-9-oxo-9,10-dihydro-1,10-phenanthroline-5-carbonitrile (6a) and 4,7-di(10H-pheno- 
thiazin-10-yl)-1,10-phenanthroline-5-carbonitrile (6b). Both molecules were possibly obtained 
through a reaction of oxidative nucleophilic substitutions of hydrogen (ONSH) of the type SNArH, 
with hydroxide ion as a nucleophile and in the presence of air as oxidized reagent [29,30]. In both 
cases nucleophile attacks were selective only at C2 rather than at the C9 position. The natural atomic 
charges show that both heterocycles possess greater electron density on the C2 (0.040 for compound 
5m, and 0.038 for compound 5n) than on the C9 position (0.046 for compound 5m and 0.044 for 
compound 5n) (Figures S1 and S2; Supporting Information). Both compounds 6a and 6b were isolated 
in a crystalline form, and their structures were characterized by X-ray crystallography. The prepared 
4,7-dichloro-1,10-phenanthrolines 4 tend to undergo a fragmentation with the initial loss of chloride, 
followed by the loss of a second chloride and further decomposition, with the exception of molecule 
4j, which first eliminates bromide. 
2.3. X-ray Studies 
Crystals of compounds 5d, 6a and 6b were mounted in turn on a Gemini A Ultra Oxford 
Diffraction automatic diffractometer equipped with a CCD detector used for data collection. X-ray 
intensity data were collected with graphite monochromated MoKα radiation at room temperature, 
with ω scan mode. Details concerning crystal data and refinement are gathered in Table 1 in ESI. 
Lorentz, polarization and empirical absorption correction using spherical harmonics implemented in 
SCALE3 ABSPACK scaling algorithm were applied [31]. The structures were solved by a direct 
method and subsequently completed by a difference Fourier recycling. All the non-hydrogen atoms 
were refined anisotropically using full-matrix, least-squares techniques. The Olex2 [32] and SHELXS, 
SHELXL [33] programs were used for all the calculations. Atomic scattering factors were 
incorporated in the computer programs. 
The performed investigations on the X-ray studies were inspired by the work of G. Zucchi et al. 
and K.J. Shaffer et al. [25,28]. Presented here compounds crystalize in the triclinic P–1 space group as 
a solvate with two CHCl3 molecules 5d and two THF and one methanol molecules in the case of 
compounds 6a and 6b crystalizes in monoclinic P21/c space group with two THF molecules. The 
molecular structures are displayed as ORTEP representation in Figure 1a–c. 
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(a)                                            (b) 
 
(c) 
Figure 1. (a) ORTEP drawings of compound 5d with 30% probability. The solvent molecules and 
fluorine disorder were omitted for clarity. (b) ORTEP drawings of compound 6a with 30% probability. 
The solvent molecules were omitted for clarity. (c) ORTEP drawings of compound 6b with 30% 
probability. Hydrogen atoms and solvent molecules are omitted for clarity. 
The intra- and intermolecular hydrogen bonds in the structures of compounds 5d and 6a, 6b are 
listed in Table S2 in the Supporting Information. The 1,10-pPhenanthroline moiety is in a planar 
orientation with a ring puckering amplitude of 0.105 in molecule 5d and 0.05 and 0.07 in the cases of 
compounds 6a and 6b, respectively. In the structure of heterocycle 5d C-Cl…π interactions are 
visible, while in molecules 6a and 6b π…π stacking occurs between phenanthroline rings with 
centroid-centroid distances of 3.89 Å and 3.78 Å and shift distances of 1.91 Å and 1.07 Å, respectively 
(Table S3; Supporting Information). The interaction between the nitrile C(13)-N(3) group causes 
flattening of 10H-phenothiazine ring in the position C7. The 10H-phenothiazine ring in position C4 
shows a characteristic, for this type of heterocyclic compounds, deviation of the sulfur atom position 
from the plane delimited by the benzene rings. The structures of compounds 5d, 6a and 6b are 
constitutionally related to 4,7-di(10H-phenoxazin-10-yl)-1,10-phenanthroline and 4,7-di(9H-carbazol-
9-yl)-1,10-phenanthroline [25,28]. Similarly to two other compounds which are composed of a 1,10-
phenanthroline core and two peripheral amino substituents, the 9H-carbazol-9-yl and 10H-
phenoxazin-10-yl substituents are strongly twisted in relation to the 1,10-phenanthroline rings with 
a larger angle (~87°) between 1,10-phenanthroline and substituent planes in the position C7 than C4 
(~83°). It is noticed that bond lengths between carbon atoms at C4/3 and C7/8 positions and 
pyrrolidinyl, 9H carbazol-9-yl and 10H-phenothiazin-10-yl groups 1.360 Å, 1.420 Å and 1.434(3) Å, 
respectively, are comparable to the values of 1.42 Å in 4,7-di(9H-carbazol-9-yl)-1,10-phenanthroline 
or 1.43 Å for 4,7-di(10H-phenoxazin-10-yl)-1,10-phenanthroline. The π-conjugated system derived 
from 1,10-phenanthroline core and two peripheral 9H-carbazole or 10H-phenoxazine rings showed 
less extended delocalization than that of pyrrolidinyl group over the entire π-conjugated systems, 
because the lone pair of nitrogen atom and the 1,10-phenanthroline core are not in the same plane. 
9H-carbazole and 10H-phenothiazine rings are perpendicular to the 1,10-phenanthroline moiety 
[25,28]. 
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2.4. NMR Studies 
13C CP/MAS NMR spectra of compounds 4 and 5 displayed readily discernible aliphatic carbon 
signals such as methyl, and distinguishable resonance lines attributed to aromatic carbons. In general, 
the signals in the solution and in the solid state are in good agreement (Tables S5 and S6; Supporting 
Information). To investigate the character of nitrogen atoms which are responsible for their bidentate 
coordination abilities, studies using the 15N CP/MAS NMR technique were carried out, which is a 
highly sensitive probe and allows being monitored even in subtle changes in molecular constitution 
and electronic structures. Due to the symmetry of 4e, 5c and 5f molecules only one or two lines are 
presence in 15N CP/MAS NMR spectrum, respectively (Table S7; Supporting Information). 
Comparing the experimental CP/MAS 15N chemical shifts of selected heterocyles 4 and 5, the 
influence of substituents originated from chlorine atoms, methyl group and N-donor fragments i.e., 
NH2, pyrrolidine, 9H-carbazole and 10H-phenothiazine could be observed. It is worth noting that the 
15N chemical shift of a free 1,10-phenanthroline (or 2,9-dimethyl-1,10-phenanthroline) molecule is 
equal to −74.4 (or −80.2) ppm in the absolute scale [34,35]. A significant impact on the 15N chemical 
shifts of pyridine nitrogen has been seen with pyrrolidine and 10H-phenothiazine substituents (Table 
S7; Supporting Information). For pyridine rings, the dominant contribution to nitrogen shielding is 
associated with a n → π* excitation, and low transition energies correlate with large deshieldings. 
Interestingly, 9H-carbazole and 10H-phenothiazine fragments have higher impact on one of the two 
pyridine nitrogen atoms. One is significantly deshielded (downfield effect, larger δ) with 11.14 ppm 
of difference for molecule 5k or 23.78 ppm of difference for compound 5h (Table S7). In contrast, N-
donor substituents i.e., NH2, pyrrolidine, 9H-carbazole and 10H-phenothiazine are characterized by 
the more negative value of 15N chemical shift (−249.48 to −317.08 ppm). 
2.5. Cyclic Voltammetry 
The electrochemical behaviour of selected substituted 1,10-phenanthroline derivatives in 
acetonitrile was studied by cyclic voltammetry on a glassy carbon electrode. Compounds 4 
substituted by chlorine atoms (R2 substituent) yield rather complex cyclic voltammograms mainly in 
the negative potential regions (Figure 2). In the case of all compounds 4 the first reduction wave 
corresponds to the formation of anion radical and according to literature the subsequent cleavage of 
chlorine from position R2 in the overall ECE process follows [36,37]. The compounds 4b and 4i were 
found to be the most easily reduced because of the presence of chlorine and fluorine atoms as R1. In 
the case of compound 4i the first reduction step may be attributed to the cleavage of chlorine (R1) 
from primarily formed radical anion. Calculated HOMO and LUMO spatial distributions of sterically 
symmetrical compounds are shown in Table 1 and results for other electrochemically investigated 
compounds are summarized in Tables S8 and S9 in the Supporting Information. A linear relationship 
of LUMO energy on reduction potential was observed for compounds from series 4 and 5 (except 
compounds 5a and 5c) showing that the first reduction step proceeds on 1,10-phenanthroline rings 
and an anion radical is formed (Figure 3). Compounds 5a and 5c are substituted with pyrrolidine and 
their reduction may follow another mechanism. These two compounds differ from the others also by 
high values of their dipole moments as indicated in Table 2. The substituent effect on the reduction 
and oxidation potentials of selected compounds was summarized in Table 2. Methyl group as R 
substituent significantly influenced reduction potential of compounds towards more negative values 
(compounds 4g, 4k, 5c compare to 4a, 4d, 5a, respectively). The oxidation of all compounds 4 may 
lead to the formation of cation radicals [38]. The dependences of the highest occupied molecular 
orbital energy on the first oxidation potential were linear for both series of compounds, substituents 
R2 with chlorine atoms 4 and N-heterocycles 5. Their independence is related to their different 
oxidation mechanism, resulting from the different electroactive site visible from the spatial 
distribution of HOMO orbitals (Table 1). Oxidation of phenothiazine is known in the literature 
[39,40]. Detailed investigation of reduction and oxidation mechanism of both series will be further 
plan of our research. Figure 3C shows a linear relationship between the energy difference of HOMO 
and LUMO orbitals and the potential gap ΔE obtained experimentally. 
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Figure 2. Cyclic voltammograms of 0.60 mM 4a, 4g, 4i, 4n and 0.50 mM 4b, 4d and 0.12 mM 4k in 
acetonitrile at 0.1 V/s (0.1 M TBAPF6). 
 
Figure 3. Dependence of HOMO (A) and LUMO (B) energies on the experimental oxidation and 
reduction potentials, respectively. Panel (C) shows a dependence of HOMO and LUMO energies 
difference on electrochemical gap, Eox and Ered. 
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Table 1. Chemical structures and HOMO and LUMO distribution of selected compounds. 
 HOMO LUMO 
4a 
  
4n 
  
5a 
  
5f 
  
5i 
  
Table 2. Experimentally obtained electrochemical data (the first oxidation Ep1ox and the first reduction 
potential Ep1red) at glassy carbon electrode, and calculated energies of HOMO and LUMO by DFT 
(B3LYP/6-31G*). 
No. Ep1ox/V Ep1red/V Dipole µ (calc.)/D EHOMO/eV ELUMO/eV 
4a 1.181 −1.572 0.74 −6.56 −1.89 
4d 1.212 −1.471 1.12 −6.36 −1.79 
4g 1.221 −1.670 0.47 −6.31 −1.66 
4i 1.253 −1.330 2.14 −6.31 −1.90 
4b 1.312 −1.331 0.46 −6.51 −1.97 
4k 1.601 −1.582 0.24 −6.14 −1.60 
4n 1.971 −1.911 3.23 −6.25 −1.41 
5k 0.668 −1.185 0.39 −5.08 −1.75 
5c 0.900 −1.560 4.37 −5.21 −0.85 
5a 0.905 −1.505 5.38 −5.41 −1.05 
5i 0.951 −1.231 0.47 −5.17 −1.76 
5j 0.956 −1.205 2.47 −5.04 −1.95 
5h 1.238 −1.235 1.53 −5.59 −1.74 
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5g 1.325 −1.205 0.61 −5.55 −1.90 
5f 1.575 −1.365 1.42 −5.61 −1.80 
3. Materials and Methods 
3.1. Materials 
All experiments were carried out in an atmosphere of dry argon and flasks were flame dried. 
Solvents were dried by usual methods (diphenyl ether, diethyl ether and THF over benzophenone 
ketyl, CHCl3 and CH2Cl2 over P4O10, hexane over sodium-potassium alloy) and distilled. 
Chromatographic purification was carried out on silica gel 60 (0.15–0.3 mm, Macherey-Nagel GmbH 
& Co. KG, Düren, Germany). Sodium hydride (dry, 95%), trimethyl orthoformate, triethyl 
orthoformate, triethyl orthoacetate, trimethyl orthoacetate, 1,10-phenanthroline (4n), 1,10-
phenanthrolin-5-amine (5l), 9H-carbazole, pyrrolidine, 10H-phenothiazine, Meldrum’s acid, 
benzene-1,2-diamine, 4-fluorobenzene-1,2-diamine, 4-chlorobenzene-1,2-diamine, 4-bromobenzene-
1,2-diamine, 4-methylbenzene-1,2-diamine, 3,4-diaminobenzonitrile and 3,4-diaminobenzoic acid 
were purchased from Sigma–Aldrich (Poznan, Poland), and were used without further purification. 
3.2. Instrumentation 
NMR spectra were obtained with Avance 400, 500 and 600 spectrometers (Bruker, Billerica, MA, 
USA) operating at 600.2, 500.2 or 400.1 MHz (1H), 150, 125.78 or 100.5 MHz (13C) and 470.5 MHz (19F) 
at 21 °C, and a Bruker Avance 400WB; 100.65 MHz for 13C, 40.55 MHz for 15N. Chemical shifts 
referenced to ext. TMS (1H, 13C), CFCl3 (19F) and ext. DSS (1H, 13C), or using the residual CHCl3 signal 
(δH 7.26 ppm) and CDCl3 (δC 77.1 ppm) as internal references for 1H and 13C NMR, respectively. 
Coupling constants are given in Hz. High-resolution solid-state Cross-Polarization (CP) 13C- and 15N-
NMR experiments were made with magic-angle spinning (MAS) at 5 and 7 kHz. Experiments were 
done with a 4000 scans, a contact time of 2 ms, a repetition time of 25 s, using 4 and 7 mm Bruker 
probes. For GC-MS a 7890A gas chromatograph (Agilent Technologies, Wilmington, DE, USA) 
equipped with a MS (70 eV) 5975 EI/CI MSD, and a 7693 autosampler with an Agilent HP-5MS 
capillary column (30 m × 250 μm × 0.25 μm) - press. 127.5 kPa, total flow 19 mL/min, col. flow 2 
mL/min, split - 7:1, temp. prog. (70 °C - hold 0.5 min, 70–290 °C/25 °C/min., 290 °C - hold 6 min) was 
used. The LCMS-IT-TOF analysis was performed on an Agilent 1200 Series binary LC system coupled 
to a micrOTOF-Q system mass spectrometer (Bruker Daltonics, Brema, Germany). High-resolution 
mass spectrometry (HRMS) measurements were performed using a Synapt G2-Si mass spectrometer 
(Waters, New Castle, DE USA) equipped with an ESI source and quadrupole-time-of-flight mass 
analyser. To ensure accurate mass measurements, data were collected in centroid mode and mass 
was corrected during acquisition using leucine enkephalin solution as an external reference (Lock-
SprayTM). The results of the measurements were processed using the MassLynx 4.1 software (Waters) 
incorporated within the instrument. A Nicolet iS50 FTIR spectrometer was used for recording spectra 
in the IR range 4000–400 cm−1. FTIR spectra were recorded on a Perkin Elmer (Schwerzenbach, 
Switzerland) spectrophotometer in the spectral range 4000–450 cm−1 with the samples in the form of 
KBr pellets. Elementary analysis was performed using Vario EL III apparatus (Elementar, 
Langenselbold, Germany). Melting points were determined on MPA100 OptiMelt melting point 
apparatus (Stanford Research Systems, Sunnyvale, CA USA) and are uncorrected. 
3.3. General Procedures for Synthesis of 4,7-dichloro-1,10-phenanthrolines  
These syntheses were based on procedures described in the literature [22,23].  
3.3.1. Step A. 
Triethyl orthoformate or trimethyl orthoformate were used in the synthesis of 2a, 2b, 2c, 2d, 2e, 
2f and 2g and triethyl orthoacetate or trimethyl orthoacetate for 2h, 2i, 2j, 2k, 2l, 2m, 2n and 2o. The 
orthoester (triethyl orthoformate, triethyl orthoacetate, trimethyl orthoformate or trimethyl 
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orthoacetate, 330.0 mmol) and Meldrum’s acid (1.7 g, 12.0 mmol) was brought to a gentle reflux for 
15 min. The resulting greenish solution was cooled to 80 °C and the appropriate benzene-1,2-diamine 
1 (5.5 mmol) was added portionwise (caution: exothermic reaction). The resulting mixture was 
stirring up to reflux for 2 h, and left under r.t. for 16 h. Subsequently, diethyl ether or hexane was 
added and the solution was cooled to −35 °C where a precipitate formed. The precipitate was filtered 
off, washed with diethyl ether (4 × 100 mL) and dried to afford a solid: 
1,2-Bis-[(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidenemethyl)amino]benzene (2a) [23,41]; white solid 2.0 g 
(4.7 mmol, 86%); m.pdec. = 207.6 °C. 
5,5′-(((4-Fluoro-1,2-phenylene)bis(azanediyl))bis(methaneylylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-dione) 
(2b); white; 2.0 g (4.6 mmol, 83%); m.pdec. = 216 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.73 (s, 6H, 2CH3), 
1.74 (s, 6H, 2CH3), 7.06–7.12 (dt, 3JH,H = 8.1 Hz, 4JF,H = 2.6 Hz, 1H, aromatic), 7.20 (dd, 3JF,H = 8.7 Hz, 4JH,H 
= 2.5 Hz, 1H, aromatic), 7.38 (dd, 3JF,H = 8.9 Hz, 3JH,H = 5.1 Hz, aromatic), 8.38 (d, 3JH,H = 13.5 Hz, 1H, 
vinyl), 8.52 (d, 3JH,H = 13.4 Hz, 1H, vinyl), 11.15 (d, 3JH,H = 13.5 Hz, 1H, NH), 11.42 (d, 3JH,H = 13.3 Hz, 
1H, NH); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 27.2, 27.3, 89.6, 90.3, 105.8 (d, 3JC,F = 14.3 Hz), 107.4 
(d, 2JC,F = 26.8 Hz), 115.0 (d, 2JC,F = 22.9 Hz), 124.9 (d, 4JC,F = 9.5 Hz), 126.9, 133.3 (d, 3JC,F = 10.1 Hz), 161.1, 
155.1 (d, 1JC,F = 342.9 Hz), 162.9, 163.2, 165.4, 165.5; 19F{1H}-NMR (CDCl3; 470.5 MHz) δ = −108.94; 19F- 
NMR (CDCl3; 470.5 MHz) δ = −108.94 (dd, 3JF,H = 12.9 Hz, 3JF,H = 7.8 Hz); UV-Vis (methanol; λ [nm] 
(logε)): 329 (4.48), 292 (4.56), 212 (4.43).  
5,5′-(((4-Chloro-1,2-phenylene)bis(azanediyl))bis(methaneylylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-dione) 
(2c) [23]; white; 2.1 g (4.6 mmol, 84%); m.pdec. = 202.7 °C; UV-Vis (methanol; λ [nm] (logε)): 332 (4.59), 
296 (4.75), 223 (4.47), 206 (4.46).  
5,5′-(((4-Methyl-1,2-phenylene)bis(azanediyl))bis(methaneylylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-dione) 
(2d); white; 2.2 g (5.2 mmol, 94%) [41]; m.pdec. = 212 °C; UV-Vis (methanol; λ [nm] (logε)): 330 (4.85), 
296 (4.93), 221 (4.83).  
3,4-Bis(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)benzonitrile (2e); beige, 1.7 g (3.8 
mmol, 69%); m.pdec. = 250 °C; 1H-NMR (DMSO-d6; 400.2 MHz) δ = 1.68 (s, 6H, 2CH3), 1.68 (s, 6H, 
2CH3), 7.81-7.84 (m, 2H, aromatic), 8.16 (dd, 3JH,H = 4.3 Hz, 4JH,H = 0.8 Hz, 1H, aromatic), 8.33 (d, 3JH,H = 
14.1 Hz, 1H, vinyl), 8.41 (d, 3JH,H = 13.9 Hz, 1H, vinyl), 11.33 (d, 3JH,H = 14.1 Hz, 1H, NH), 11.43 (d, 3JH,H 
= 14.0 Hz, 1H, NH); 13C{1H}-NMR (DMSO-d6; 125.78 MHz) δ = 26.5, 26.6, 88.3, 88.8, 104.1, 104.3, 110.0, 
117.4, 122.7, 128.0, 132.0, 133.6, 137.5, 155.6, 157.4, 162.3, 162.5, 163.5, 163.6; UV-Vis (methanol; λ [nm] 
(logε)): 342 (4.11), 296 (4.19), 219 (4.00).  
3,4-Bis(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)benzoic acid (2f); beige, 0.8 g (1.8 
mmol, 32%); m.pdec. = 225 °C; 1H NMR (CDCl3; 400.2 MHz) δ = 1.77 (s, 6H, 2CH3), 1.79 (s, 6H, 2CH3), 
7.50 (d, 3JH,H = 8.5 Hz, 1H, aromatic), 8.14 (d, 3JH,H = 8.9 Hz, 1H, aromatic), 8.50 (s, 1H, aromatic), 8.59 
(d, 3JH,H = 13.1 Hz, 1H, vinyl), 8.99 (d, 3JH,H = 12.7 Hz, 1H, vinyl), 11.51 (d, 3JH,H = 12.6 Hz, 1H, NH), 
11.66 (d, 3JH,H = 12.9 Hz, 1H, NH); 1H-NMR (DMSO-d6; 500.2 MHz) δ = 1.68 (s, 6H, 2CH3), 1.68 (s, 6H, 
2CH3), 7.74 (d, 3JH,H = 8.4 Hz, 1H, aromatic), 7.96 (dd, 3JH,H = 8.3 Hz, 4JH,H = 1.7 Hz, 1H, aromatic), 8.03 
(d, 4JH,H = 1.7 Hz, 1H, aromatic), 8.24 (d, 3JH,H = 14.2 Hz, 1H, vinyl), 8.40 (d, 3JH,H = 14.1 Hz, 1H, vinyl), 
11.35 (d, 3JH,H = 14.3 Hz, 1H, NH), 11.44 (d, 3JH,H = 14.1 Hz, 1H, NH); 13C{1H}-NMR (DMSO-d6; 125.78 
MHz) δ = 26.50, 26.52, 87.8, 88.2, 104.0, 104.1, 121.9, 125.1, 129.3, 130.0, 133.1, 137.2, 155.7, 157.5, 162.4, 
162.7, 163.4, 163.6, 165.9, 168.2; UV-Vis (methanol; λ [nm] (logε)): 340 (3.96),303 (3.87) 274 (3.82), 220 
(4.00). 
Methyl 3,4-bis(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)benzoate (2g); beige, 1.6 g (3.5 
mmol, 63%); m.pdec. = 225 °C; 1H-NMR (DMSO-d6; 500.2 MHz) δ = 1.68 (s, 6H, 2CH3), 1.69 (s, 6H, 
2CH3), 4.00 (s, 3H, OCH3), 7.39 (d, 3JH,H = 8.3 Hz, 1H, aromatic), 7.76 (dd, 3JH,H = 8.2 Hz, 4JH,H = 1.7 Hz, 
1H, aromatic), 8.18 (d, 4JH,H = 1.6 Hz, 1H, aromatic), 8.24 (d, 3JH,H = 14.5 Hz, 1H, vinyl), 8.81 (d, 3JH,H = 
14.7 Hz, 1H, vinyl), 11.40 (d, 3JH,H = 14.1 Hz, 2H, NH), 11.84 (d, 3JH,H = 14.8 Hz, 2H, NH); 13C{1H}-NMR 
(DMSO-d6; 125.78 MHz) δ = 26.47, 26.52, 54.2, 87.2, 87.7, 104.39, 104.38, 116.0, 119.9, 127.2, 128.0, 131.3, 
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140.1, 151.3, 159.3, 162.5, 164.7, 166.6, 172.6; UV-Vis (methanol; λ [nm] (logε)): 340 (3.96),300 (3.87) 275 
(3.82), 220 (4.00).  
5,5′-((1,2-Phenylenebis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-dione) (2h) 
[22,23]; white; 1.2 g (2.8 mmol, 51%); m.pdec. = 189.6 °C.  
5,5′-(((4-Fluoro-1,2-phenylene)bis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-
dione) (2i); white, 0.9 g (2.0 mmol, 36%); m.pdec.. = 218.0 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.70 (s, 
6H, 2CH3), 1.71 (s, 6H, 2CH3), 2.50 (s, 3H, CH3), 2.58 (s, 3H, CH3), 7.12 (dd, 3JH,F = 8.2 Hz, 4JH,H = 2.3 Hz, 
1H, aromatic), 7.18-7.20 (m, 1H, aromatic), 7.35 (dd, 3JH,F = 8.7 Hz, 3JH,H = 5.4 Hz, 1H, aromatic), 12.68 
(s, 1H, NH), 12.85 (s, 1H, NH); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 19.6, 19.7, 26.7, 26.7, 87.6, 88.0, 
103.4, 103.5, 115.4 (d, 2JC,F = 24.8 Hz), 116.4 (d, 2JC,F = 22.4 Hz), 128.5 (d, 4JC,F = 3.7 Hz), 129.7 (d, 3JC,F = 9.5 
Hz), 134.1 (d, 3JC,F = 10.3 Hz), 161.8 (d, 1JC,F = 252.9 Hz), 162.3, 162.5, 167.7, 167.6, 172.8, 173.5; 19F{1H}-
NMR (CDCl3; 470.5 MHz) δ = −108.53; 19F-NMR (CDCl3; 470.5 MHz) δ = −108.53 (dd, 3JF,H = 13.3 Hz, 
4JF,H = 7.7 Hz); UV-Vis (methanol; λ [nm] (logε)): 311 (4.30), 283 (4.66), 226 (4.38), 201 (4.27).  
5,5′-(((4-Chloro-1,2-phenylene)bis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-
dione) (2j); white, 1.4 g (2.9 mmol, 52%); mpdec. = 203.8 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.71 (s, 
12H, 4CH3), 2.53 (s, 3H, CH3), 2.56 (s, 3H, CH3), 7.30 (d, 3JH,H = 8.5 Hz, 1H, aromatic), 7.38 (d, 4JH,H = 1.6 
Hz, 1H, aromatic), 7.48 (dd, 3JH,H = 8.5 Hz, 4JH,H = 1.8 Hz, 1H, aromatic), 12.76 (s, 1H, NH), 12.81 (s, 1H, 
NH); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 19.7, 19.7, 26.7, 87.9, 88.0, 103.5, 103.5, 128.1, 129.0, 129.5, 
131.1, 133.6, 135.0, 162.3, 162.4, 167.7, 167.7, 173.0, 173.1; UV-Vis (methanol; λ [nm] (logε)): 315 (4.36), 
285 (4.74), 226 (4.46), 202 (4.38). 
5,5′-(((4-Bromo-1,2-phenylene)bis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-
dione) (2k); white, 0.9 g (1.8 mmol, 32%); m.pdec. = 204.6 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.71 (s, 
12H, 4CH3), 2.53 (s, 3H, CH3), 2.56 (s, 3H, CH3), 7.23 (d, 3JH,H = 8.5 Hz, 1H, aromatic), 7.53 (d, 4JH,H = 1.5 
Hz, 1H, aromatic), 7.63 (dd, 3JH,H = 8.5 Hz, 4JH,H = 1.7 Hz, 1H, aromatic), 12.76 (s, 1H, NH), 12.81 (s, 1H, 
NH); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 19.6, 19.7, 26.6, 87.7, 87.8, 103.4, 103.4, 122.3, 129.1, 131.0, 
131.6, 132.4, 133.7, 162.2, 162.3, 167.5, 172.9; UV-Vis (methanol; λ [nm] (logε)): 313 (4.29), 284 (4.65), 
226 (4.38), 201 (4.37). 
5,5′-(((4-Methyl-1,2-phenylene)bis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-
dione) (2l); white, 1.3 g (2.9 mmol, 52%); m.pdec. = 204.2 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.70 (s, 
12H, 4CH3), 2.45 (s, 3H, CH3), 2.51 (s, 3H, CH3), 2.52 (s, 3H, CH3), 7.17 (s, 1H, aromatic), 7.23 (d, 3JH,H 
= 8.1 Hz, 1H, aromatic), 7.30 (d, 3JH,H = 8.3 Hz, 1H, aromatic), 12.68 (s, 1H, NH), 12.71 (s, 1H, NH); 
13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 19.6, 19.6, 21.2, 26.6, 87.1, 87.2, 103.2, 127.7, 128.5, 129.8, 130.1, 
132.2, 140.1, 162.5, 162.5, 167.6, 173.2, 173.4; UV-Vis (methanol; λ [nm] (logε)): 319 (4.12), 283 (4.60), 
227 (4.38), 203 (4.23). 
3,4-Bis((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)benzonitrile (2m); white, 1.0 g (2.2 
mmol, 40%); m.pdec. = 205.6 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.72 (bs, 12H, 4CH3), 2.55 (s, 3H, 
CH3), 2.61 (s, 3H, CH3), 7.49 (d, 3JH,H = 8.2 Hz, 1H, aromatic), 7.68 (s, 1H, aromatic), 7.78 (d, 3JH,H = 8.2 
Hz, 1H, aromatic), 12.87 (s, 1H, NH), 13.04 (s, 1H, NH); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 19.7, 
19.9, 26.8, 26.8, 88.6, 89.0, 103.7, 103.7, 112.7, 116.7, 128.2, 131.6, 132.6, 133.1, 136.9, 162.1, 162.2, 167.7, 
167.7, 172.2, 172.9; UV-Vis (methanol; λ [nm] (logε)): 324 (4.27), 289 (4.58), 224 (4.40), 204 (4.40).  
Methyl 3,4-bis((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)benzoate (2n); white, 1.2 g (2.3 
mmol, 42%); m.pdec. = 184.8 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.72 (s, 6H, 2CH3), 1.73 (s, 6H, 2CH3), 
2.55 (s, 3H, CH3), 2.60 (s, 3H, CH3), 3.98 (s, 3H, OCH3), 7.44 (d, 3JH,H = 8.3 Hz, 1H, aromatic), 8.03 (s, 
1H, aromatic), 8.15 (d, 3JH,H = 8.2 Hz, 1H, aromatic), 12.84 (s, 1H, NH), 12.97 (s, 1H, NH); 13C{1H}-NMR 
(CDCl3; 125.78 MHz) δ = 19.7, 19.9, 26.7, 26.8, 53.0, 88.0, 88.4, 103.5, 103.6, 127.5, 129.2, 130.2, 130.8, 
132.3, 136.4, 162.3, 162.4, 165.0, 167.7, 167.7, 172.6; UV-Vis (methanol; λ [nm] (logε)): 323 (4.61), 289 
(4.96), 226 (4.75), 203 (4.65).  
Ethyl 3,4-bis((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)benzoate (2o); white, 0.9 g (1.7 
mmol, 31%); m.pdec. = 171.4 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.42 (t, 3JH,H = 7.0 Hz, 3H, CH3), 1.71 
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(s, 6H, 2CH3), 1.72 (s, 6H, 2CH3), 2.54 (s, 3H, CH3), 2.59 (s, 3H, CH3), 4.43 (q, 3JH,H = 7.1 Hz, 2H, OCH2), 
7.43 (d, 3JH,H = 8.2 Hz, 1H, aromatic), 8.02 (s, 1H, aromatic), 8.15 (d, 3JH,H = 8.1 Hz, 1H, aromatic), 12.82 
(s, 1H, NH), 12.95 (s, 1H, NH); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 14.4, 19.7, 19.9, 26.7, 26.7, 62.1, 
87.9, 88.3, 103.5, 103.5, 127.5, 129.2, 130.2, 131.2, 132.2, 136.3, 162.3, 162.4, 164.4, 167.7, 167.7, 172.6, 
173.3; UV-Vis (methanol; λ [nm] (logε)): 321 (4.25), 287 (4.63), 225 (4.44), 204 (4.35).  
1H-benzo[d]imidazole-6-carboxylic acid; m.pdec. = 278.0-280.0 °C; 1H-NMR (DMSO-d6/KOD; 500.2 MHz) 
δ = 7.74 (d, 3JH,H = 8.7 Hz, 1H, aromatic), 7.96 (d, 3JH,H = 8.7 Hz, 4JH,H = 1.4 Hz, 1H, aromatic), 8.23 (s, 1H, 
aromatic), 9.08 (s, 1H, aromatic); 1H-NMR (D2O/KOD; 500.18 MHz) δ = 7.66 (d, 3JH,H = 8.5 Hz, 1H, 
aromatic), 7.81 (dd, 3JH,H = 8.5 Hz, 4JH,H = 1.5 Hz, 1H, aromatic), 8.21 (s, 1H, aromatic), 8.36 (s, 1H, 
aromatic); 13C{1H}-NMR (DMSO-d6/KOD; 125.78 MHz) δ = 116.0, 117.9, 128.4, 130.4, 132.1, 135.0, 
143.1, 170.8; 13C{1H}-NMR (D2O/KOD; 125.78 MHz) δ = 115.3 (bs), 118.3 (bs), 123.8, 124.8, 144.7, 168.4; 
HRMS (IT TOF): m/z Calcd for C8H7N2O2 [M + H]+= 163.0508, Found 163.0509. 
3.3.2. Step B  
Modifications to existing procedures described in the literature [22,23] rely on purifications. The 
crude products were extracted with hexane or toluene at Soxhlet apparatus. Into freshly distillated 
diphenyl ether (50 mL) at 240 °C was added compound 2 (10.0 mmol) in small portions, resulting in 
vigorous gas evolution. The resulting orange solution was brought to reflux for 30 min, and was then 
allowed to cool to 70 °C. The acetone or hexane (25 mL) was added and a dark-brown solid 
precipitated was filtered, washed with acetone (2 × 10 mL). The crude product was extracted with 
hexane or toluene at Soxhlet apparatus to yield solid as follows: 
1,10-Dihydro-1,10-phenanthroline-4,7-dione (3a); [41] brown; 1.4 g (6.8 mmol, 68%); m.pdec. > 350 °C; 1H- 
NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 6.62 (d, 3JH,H = 5.6 Hz, 2H, aromatic), 8.08 (s, 2H, aromatic), 
8.36 (d, 3JH,H = 5.6 Hz, 2H, aromatic); 13C{1H}-NMR (CD3OD/KOD/D2O; 100.5 MHz) δ = 111.6, 118.8, 
127.0, 148.8, 150.5, 174.7.  
5-Fluoro-1,10-dihydro-1,10-phenanthroline-4,7-dione (3b); brown; 1.8 g (7.7 mmol, 77%); m.pdec. >350.0 
°C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 6.45 (d, 3JH,H = 6.5 Hz, 1H, aromatic), 6.50 (d, 3JH,H = 
6.2 Hz, 1H, aromatic), 7.31 (d, 3JH,F = 14.1 Hz, 1H, aromatic), 8.01 (d, 3JH,H = 6.4 Hz, 1H, aromatic), 8.10 
(d, 3JH,H = 6.1 Hz, 1H, aromatic); 13C{1H}-NMR (CD3OD/KOD/D2O; 100.5 MHz) δ = 101.1 (d, 2JC,F = 24.1 
Hz), 113.0 (d, 1JC,F = 307.7 Hz), 117.6 (d, 2JC,F = 11.3 Hz), 125.0 (d, 3JC,F = 9.6 Hz), 130.7, 136.4, 142.9, 143.4, 
147.9, 156.4, 158.9, 175.7, 176.9; GC-MS: tr = 5.1 min, (EI) M+ = 230 (< 1%); 19F{1H}-NMR 
(CD3OD/KOD/D2O; 470.5 MHz) δ = −119.68; 19F-NMR (CD3OD/KOD/D2O; 470.5 MHz) δ = −119.68 (d, 
3JF,H = 13.8 Hz); UV-Vis (methanol; λ [nm] (logε)): 352 (3.40), 329 (3.61), 308 (3.55), 273 (3.56), 251 (3.63), 
224 (3.91), 208 (3.96).  
5-Chloro-1,10-dihydro-1,10-phenanthroline-4,7-dione (3c); brown; [23]; 1.5 g (6.1 mmol, 61%); m.pdec. = 
272.8-273.6 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 6.62 (d, 3JH,H = 6.9 Hz, 1H, aromatic), 6.64 
(d, 3JH,H = 6.4 Hz, 1H, aromatic), 8.27 (d, 3JH,H = 5.9 Hz, 1H, aromatic), 8.31 (d, 3JH,H = 5.8 Hz, 1H, 
aromatic); 13C{1H}-NMR (CD3OD/KOD/D2O; 100.5 MHz) δ = 112.0, 114.5, 120.3, 122.5, 125.4, 126.1, 
144.0, 147.1, 148.6, 149.4, 169.3, 173.7, 173.8, 176.0, 176.1; GC-MS: tr = 11.5 min, (EI) M+ = 246 (100%), 
248 (32%), [M + H]+ = 247 (8%), [M-CO]+ = 218 (90%); UV-Vis (methanol; λ [nm] (logε)): 356 (3.83), 338 
(4.06), 324 (4.06), 285 (3.97), 273 (4.03), 249 (4.42), 231 (4.28), 215 (4.42).  
5-Methyl-1,10-dihydro-1,10-phenanthroline-4,7-dione (3d); brown; 1.9 g (8.6 mmol, 86%); m.pdec. > 350.0 
°C; 1H-NMR (CD3OD/KOD/D2O; 500.2 MHz) δ = 2.73 (d, 4JH,H = 0.8 Hz, 3H, CH3), 6.36 (d, 3JH,H = 6.6 
Hz, 1H, aromatic), 6.48 (d, 3JH,H = 6.0 Hz, 1H, aromatic), 7.47 (d, 4JH,H = 1.0 Hz, 1H, aromatic), 7.88 (d, 
3JH,H = 6.6 Hz, 1H, aromatic), 8.08 (d, 3JH,H = 6.0 Hz, 1H, aromatic); 13C{1H}-NMR(CD3OD/KOD/D2O; 
125.78 MHz) δ = 24.5, 112.0, 114.0, 119.9, 124.9, 125.9, 132.6, 139.8, 141.0, 142.5, 148.0, 174.6, 180.9; GC-
MS: tr = 7.0 min, (EI) [M-H]+ = 225 (1%); UV-Vis (methanol; λ [nm] (logε)): 355 (3.66), 327 (3.89), 306 
(3.83), 275 (3.93), 247 (4.14), 224 (4.23), 209 (4.28).  
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4,7-Dioxo-1,4,7,10-tetrahydro-1,10-phenanthroline-5-carbonitrile (3e); beige, 1.5 g (6.4 mmol, 64%); m.pdec. 
> 350 °C; 1H-NMR (DMSO–d6/KOD/D2O; 400.2 MHz) δ = 6.37 (d, 3JH,H = 6.8 Hz, 1H, aromatic), 6.41 (d, 
3JH,H = 6.3 Hz, 1H, aromatic), 8.02 (d, 3JH,H = 6.7 Hz, 1H, aromatic), 8.16 (d, 3JH,H = 6.3 Hz, 1H, aromatic), 
8.26 (s, 1H, aromatic); 13C{1H}-NMR (DMSO–d6/KOD/D2O; 125.78 MHz) δ = 101.1, 113.7, 114.2, 122.2, 
123.3, 124.8, 131.2, 139.6, 142.2, 144.6, 149.7, 176.1, 176.8; UV-Vis (methanol; λ [nm] (logε)): 382 (3.27), 
350 (3.50), 335 (3.44), 277 (3.39), 242 (3.78), 214 (3.81).  
5-Fluoro-2,9-dimethyl-1,5,10,10a-tetrahydro-1,10-phenanthroline-4,7-dione (3f); brown; 2.2 g (8.7 mmol, 
87%); m.pdec. = 370.2–372.8 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.40 (bs, 6H, CH3), 6.26 
(bs, 1H, aromatic), 6.35 (bs, 1H, aromatic), 7.19 (bd, 3JH,F = 11.1 Hz, 1H, aromatic); 13C{1H}-NMR 
(CD3OD/KOD/D2O; 100.5 MHz) δ = 21.4, 22.9, 100.4 (d, 2JC,F = 24.2 Hz), 112.2 (d, 1JC,F = 274.4 Hz), 115.5 
(d, 2JC,F = 11.1 Hz), 123.1 (d, 3JC,F = 9.7 Hz), 135.0, 141.5 (d, 4JC,F = 3.7 Hz), 154.0, 155.8, 157.8, 158.3, 175.0, 
176.2, 176.2; GC-MS: tr = 10.5 min, (EI) M+ = 258 (100%), [M + H-CO]+ = 229 (98%).  
2,9-Dimethyl-1,10-phenanthroline-4,7(1H,10H)-dione (3g); brown; [22]; 1.6 g (6.8 mmol, 68%); m.pdec. = 
291.8–292.5 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.29 (s, 6H, CH3), 6.24 (s, 2H, aromatic), 
7.64 (s, 2H, aromatic); 13C{1H}-NMR (CD3OD/KOD/D2O; 100.5 MHz) δ = 21.8, 100.0, 110.1, 117.0, 122.9, 
138.9, 155.9, 174.6.  
5-Fluoro-2,9-dimethyl-1,5,10,10a-tetrahydro-1,10-phenanthroline-4,7-dione (3h); brown; 2.2 g (8.7 mmol, 
87%); m.pdec. = 370.2-372.8 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.40 (bs, 6H, CH3), 6.26 
(bs, 1H, aromatic), 6.35 (bs, 1H, aromatic), 7.19 (bd, 3JH,F = 11.1 Hz, 1H, aromatic); 13C{1H}-NMR 
(CD3OD/KOD/D2O; 100.5 MHz) δ = 21.4, 22.9, 100.4 (d, 2JC,F = 24.2 Hz), 112.2 (d, 1JC,F = 274.4 Hz), 115.5 
(d, 2JC,F = 11.1 Hz), 123.1 (d, 3JC,F = 9.7 Hz), 135.0, 141.5 (d, 4JC,F = 3.7 Hz), 154.0, 155.8, 157.8, 158.3, 175.0, 
176.2, 176.2; GC-MS: tr = 10.5 min, (EI) M+ = 258 (100%), [M + H-CO]+ = 229 (98%); 19F{1H}-NMR 
(CD3OD/KOD/D2O; 470.5 MHz) δ = −119.99; 19F-NMR (CD3OD/KOD/D2O; 470.5 MHz) δ = −119.99 (d, 
3JF,H = 13.9 Hz); UV-Vis (methanol; λ [nm] (logε)): 353 (3.76), 337 (3.85), 319 (4.00), 311 (3.97), 270 (4.21), 
254 (4.46), 225 (4.31), 214 (4.44).  
5-Chloro-2,9-dimethyl-1,5,10,10a-tetrahydro-1,10-phenanthroline-4,7-dione (3i); 2.3 g (8.3 mmol, 83%); 
brown; m.pdec. = 332.7–334.8 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.46 (s, 3H, CH3), 2.49 
(s, 3H, CH3), 6.40 (s, 1H, aromatic), 6.41 (s, 1H, aromatic), 7.78 (s, 1H, aromatic); 13C{1H}-NMR 
(CD3OD/KOD/D2O; 100.5 MHz) δ = 21.8, 22.6, 112.0, 114.3, 120.1, 121.1, 124.2, 126.2, 138.4, 141.6, 155.2, 
156.8, 175.9, 178.1; GC-MS: tr = 11.3 min, (EI) M+ = 273.9 (100%), [M-CO]+ = 245 (80%); UV-Vis 
(methanol; λ [nm] (logε)): 357 (3.65), 340 (3.84), 327 (3.96), 316 (3.94), 280 (4.00), 254 (4.35), 230 (4.25), 
216 (4.35).  
5-Bromo-2,9-dimethyl-1,5,10,10a-tetrahydro-1,10-phenanthroline-4,7-dione (3j); brown; 2.7 g (8.5 mmol, 
85%); m.pdec. = 325.9–326.6 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.48 (s, 3H, CH3), 2.50 (s, 
3H, CH3), 6.40 (s, 1H, aromatic), 6.43 (s, 1H, aromatic), 8.09 (s, 1H, aromatic); 13C{1H}-NMR 
(CD3OD/KOD/D2O; 100.5 MHz) δ = 21.6, 22.7, 112.2, 112.7, 113.9, 121.4, 124.4, 124.9, 138.9, 141.1, 154.4, 
157.1, 175.8, 175.8, 178.2; GC-MS: tr = 13.5 min, (EI) M+ = 318 (100%), 320 (96%), [M-CO]+ = 290 (63%); 
UV-Vis (methanol; λ [nm] (logε)): 356 (3.87), 339 (4.08), 328 (4.17), 315 (4.13), 281 (4.19), 254 (4.55), 231 
(4.46), 217 (4.53).  
2,5,9-Trimethyl-1,10-dihydro-1,10-phenanthroline-4,7-dione (3k); brown; 2.3 g (9.2 mmol, 92%); m.pdec. = 
337.4–338.9 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.31 (s, 3H, CH3), 2.36 (s, 3H, CH3), 2.66 
(s, 3H, OCH3), 6.16 (s, 1H, aromatic), 6.31 (s, 1H, aromatic), 7.28 (s, 1H, aromatic); 13C{1H}-NMR 
(CD3OD/KOD/D2O; 100.5 MHz) δ = 21.1, 23.5, 24.4, 111.4, 113.2, 119.3, 123.0, 123.9, 131.6, 138.2, 139.6, 
152.8, 157.5, 174.2, 180.3; GC-MS: tr = 12.1 min, (EI) M+ = 254 (100 %), [M + H-CO]+ = 225 (56%); UV-
Vis (methanol; λ [nm] (logε)): 354 (3.72), 338 (3.95), 320 (4.14), 282 (4.30), 257 (4.45), 226 (4.40), 217 
(4.42), 204 (4.40).  
2,9-Dimethyl-4,7-dioxo-1,4,7,10-tetrahydro-1,10-phenanthroline-5-carbonitrile (3l); brown; 1.6 g (6.2 
mmol, 62%); m.pdec. = 390.7–392.5 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.45 (s, 3H, CH3), 
2.46 (s, 3H, CH3), 6.45 (s, 1H, aromatic), 6.47 (s, 1H, aromatic), 8.21 (s, 1H, aromatic); 13C{1H}-NMR 
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(CD3OD/KOD/D2O; 100.5 MHz) δ = 23.8, 100.0, 112.1, 112.2, 122.0, 122.9, 123.3, 130.5, 144.5, 146.7, 
159.1, 159.2, 162.1, 169.4, 173.8, 174.1; GC-MS: tr = 9.4 min, (EI) M+ = 265 (5%); UV-Vis (methanol; λ 
[nm] (logε)): 350 (3.90), 343 (3.93), 328 (3.87), 286 (3.82), 276 (3.90), 252 (4.31), 228 (4.15), 217 (4.28).  
Methyl 2,9-dimethyl-4,7-dioxo-1,4,7,10-tetrahydro-1,10-phenanthroline-5-carboxylate (3m); brown; 2.3 g 
(7.8 mmol, 78%); m.pdec. = 293.8–294.3 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 2.44 (s, 6H, 
2CH3), 3.85 (s, 3H, OCH3), 6.32 (s, 1H, aromatic), 6.44 (s, 1H, aromatic), 7.78 (s, 1H, aromatic); GC-MS: 
tr = 9.3 min, (EI) [M-MeOH]+ = 266 (100%); UV-Vis (methanol; λ [nm] (logε)): 345 (3.83), 330 (4.04), 314 
(3.98), 280 (4.03), 252 (4.43), 215 (4.36).  
Ethyl 2,9-dimethyl-4,7-dioxo-1,4,7,10-tetrahydro-1,10-phenanthroline-5-carboxylate (3n); brown; 2.0 g (6.5 
mmol, 65%); m.pdec. = 301.4–301.8 °C; 1H-NMR (CD3OD/KOD/D2O; 400.2 MHz) δ = 1.41 (t, 3JH,H = 7.1 
Hz, 3H, OCH2CH3), 2.36 (s, 3H, CH3), 2.38 (s, 3H, CH3), 4.46 (q, 3JH,H = 7.0 Hz, 2H, OCH2), 6.29 (s, 1H, 
aromatic), 6.37 (s, 1H, aromatic), 7.79 (s, 1H, aromatic); GC-MS: tr = 17.9 min, (EI) M+ = 312 (50%); UV-
Vis (methanol; λ [nm] (logε)): 354 (3.58), 345 (3.81), 330 (4.04), 316 (3.99), 279 (4.03), 252 (4.44), 227 
(4.26), 214 (4.36). 
3.3.3. Step C  
Modifications to existing procedure described in the literature [22,23] rely on the evaporation of 
excess phosphoryl chloride under reduced pressure, and the addition of CH2Cl2 or CHCl3 into 
reaction mixture after alkalified by NaOH solution, because of the very exothermic hydrolysis of 
residual phosphoryl chloride. Next the crude products were purified by chromatography and 
crystallization from CH2Cl2. 
Freshly distillated phosphoryl chloride (82.0 g, 50 mL, 534.8 mmol) was mixed under argon with 
compounds 3 (5.0 mmol) and the resulting solutions were stirred at 90 °C for 4 h. The excess of 
phosphoryl chloride was slowly evaporated, under reduced pressure. The reaction mixture was 
slowly added to a well stirred mixture of ice (50 g) in water (100 mL). After stirring for 15 min. the 
resulting reaction mixture was carefully brought to pH 13–14 (pH 7 in the case of molecule 4g) by 
adding NaOH solution (40%). The aqueous layer was extracted with CH2Cl2 (4 × 10 mL). The 
combined organic layers was separated and dried over MgSO4. Evaporation of the brown colored 
solvent afforded products 4 as light tan crystals. Next, the crude products were purified by 
chromatography on silica gel using methanol/dichloromethane as eluent and finally crystallization 
from CH2Cl2 to yield precipitates as follows: 
4,7-Dichloro-1,10-phenanthroline (4a) [42,43]; beige; 1.0 g (4.2 mmol, 84%); m.pdec. = 254.8–255.0 °C; UV-
Vis (methanol; λ [nm] (logε)): 300 (3.83), 264 (4.40), 239 (4.33), 225 (4.29), 202 (4.36); IR (KBr): ν̃ = 3422, 
3034, 1563, 1487, 1418, 835, 720 cm−1 (Supporting Information Figure S1).  
4,7-Dichloro-5-fluoro-1,10-phenanthroline (4b); beige; 1.1 g (4.2 mmol, 85%); m.pdec. = 217.8–218.0 °C; 1H- 
NMR (CDCl3; 600.2 MHz) δ = 7.75 (d, 3JH,H = 4.7 Hz, 1H, aromatic), 7.77 (d, 3JH,H = 4.8 Hz, 1H, aromatic), 
7.94 (d, 3JH,F = 13.3 Hz, 1H, aromatic), 9.02 (dd, 3JH,H = 4.8 Hz, 5JH,F = 0.5 Hz, 1H, aromatic), 9.08 (d, 3JH,H 
= 4.8 Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 150.0 MHz) δ = 106.7 (d, 2JC,F = 25.9 Hz), 119.9 (d, 2JC,F = 
12.6 Hz), 124.4, 126.3, 126.8 (d, 3JC,F = 10.8 Hz), 140.3, 142.0 (d, 3JC,F = 6.2 Hz), 144.7, 148.9 (d, 4JC,F = 2.3 
Hz), 149.7 (d, 4JC,F = 2.6 Hz), 151.0, 156.3 (d, 1JC,F = 263.6 Hz); 19F{1H}-NMR (CDCl3; 470.5 MHz) δ = 
−108.98; 19F-NMR (CDCl3; 470.5 MHz) δ = −108.98 (d, 3JF,H = 13.4 Hz); GC-MS: tr = 9.0 min, (EI) M+ = 
266.0 (100%); Anal. Calcd for C12H5N2Cl2F: C, 53.96; H, 1.89; N, 10.49; Found: C, 53.90; H, 1.93; N, 
10.45; UV-Vis (methanol; λ [nm] (logε)): 305 (4.01), 268 (4.46), 240 (4.47), 225 (4.40), 203 (4.45); IR (KBr): 
ν̃ = 3422, 3035, 1626, 1571,1546, 1410, 842, 752 cm−1 (Supporting Information Figure S2).  
4,5,7-Trichloro-1,10-phenanthroline (4c) [42]; beige; 1.0 g (3.8 mmol, 75%); m.pdec. = 194.6–195.0 °C; GC-
MS: tr = 9.4 min, (EI) M+ = 281.9 (100%), 283.9 (95%), [M-Cl]+ = 247 (46%); UV-Vis (methanol; λ [nm] 
(logε)): 314 (3.82), 302 (3.87), 270 (4.32), 247 (4.31), 209 (4.30); IR (KBr): ν̃ = 3356, 3021, 2920, 2191, 1567, 
1403, 833, 716 cm−1 (Supporting Information Figure S3).  
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4,7-Dichloro-5-methyl-1,10-phenanthroline (4d) [23]; beige; 1.2 g (4.6 mmol, 91%); m.pdec. = 166.8–167.0 
°C; GC-MS: tr = 9.6 min, (EI) M+ = 262.1 (100%); UV-Vis (methanol; λ [nm] (logε)): 304 (4.09), 271 (4.50), 
241 (4.49), 225 (4.42), 205 (4.47); IR (KBr): ν̃ = 3454, 3089, 2933, 1685, 1550,1432, 1400, 1085, 844, 744 
cm−1 (Supporting Information Figure S4).  
4,7-Dichloro-1,10-phenanthroline-5-carbonitrile (4e); beige; 0.6 g (2.4 mmol, 48%); m.p. = 249.7–250.0 °C; 
1H-NMR (CDCl3; 400.2 MHz) δ = 7.84 (m, 2H, aromatic), 8.88 (s, 1H, aromatic), 9.13 (d, 3JH,H = 4.7 Hz, 
1H, aromatic), 9.19 (d, 3JH,H = 4.7 Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 108.1, 118.1, 
124.2, 125.2, 125.3, 126.5, 135.4, 142.3, 143.6, 147.5, 148.1, 151.5, 153.4; GC-MS: tr = 10.1 min, (EI) M+ = 
273.0 (100%); Anal. Calcd for C13H5N3Cl2: C, 56.96; H, 1.84; N, 15.33; Found: C, 56.90; H, 1.94; N, 15.29; 
UV-Vis (methanol; λ [nm] (logε)): 315 (3.67), 302 (3.76), 292 (3.68), 268 (4.15), 249 (4.11), 231 (4.02), 210 
(4.11); IR (KBr): ν̃ = 3406, 3029, 2224, 1569, 1498, 1406, 1084, 846, 798 cm−1 (Supporting Information 
Figure S5).  
7-Chloropyrrolo [2,3,4-de][1,10]phenanthrolin-5(4H)-one (4f) beige; m.pdec. = 310–330 °C; 1H-NMR 
(D2O/KOD; 500.18 MHz) δ = 6.47 (d, 3JH,H = 6.9 Hz, 1H, aromatic), 6.61 (d, 3JH,H = 5.9 Hz, 1H, aromatic), 
7.69 (s, 1H, aromatic), 8.05 (d, 3JH,H = 6.9 Hz, 1H, aromatic), 8.28 (d, 3JH,H = 5.9 Hz, 1H, aromatic); 1H- 
NMR (D2O/D2SO4; 400.2 MHz) δ = 7.29 (d, 3JH,H = 6.8 Hz, 1H, aromatic), 7.42 (d, 3JH,H = 6.8 Hz, 1H, 
aromatic), 8.28 (s, 1H, aromatic), 8.78 (d, 3JH,H = 6.8 Hz, 1H, aromatic), 8.87 (d, 3JH,H = 6.8 Hz, 1H, 
aromatic); 13C{1H}-NMR (D2O/KOD; 125.78 MHz) δ = 111.5, 111.6, 114.8, 120.7, 125.1, 132.5, 138.1, 
139.2, 140.7, 149.3, 173.8, 178.0, 179.7; MS-IT-TOF [M-H]- = 254 (80%), [M + H]+ = 256 (30%), HRMS (IT 
TOF): m/z Calcd for C13H7N3ClO [M + H]+ = 256.0278, Found 256.0279; UV-Vis (methanol; λ [nm] 
(logε)): 348 (3.28), 334 (3.27), 278 (3.31), 245 (3.64), 221 (3.36); IR (KBr): ν̃ = 3086, 1560, 1522, 1402, 1385, 
1363, 1026 cm−1 (Supporting Information Figure S6).  
4,7-Dichloro-2,9-dimethyl-1,10-phenanthroline (4g) [22,42,44,45]; beige; 1.3 g (4.6 mmol, 92%); m.pdec. = 
201.0–201.5 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 2.93 (s, 6H, 2CH3), 7.63 (s, 2H, aromatic), 8.24 (s, 2H, 
aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 26.0, 122.3, 124.4, 125.1, 143.0, 146.2, 160.1; CP/MAS 
13C-NMR δ = 25.1, 121.7, 141.3, 143.8, 159.3; CP/MAS 15N-NMR δ = −76.15; IR (KBr): ν̃ = 2963, 1637, 
1568, 1522, 1402, 1385, 1363, 1026 cm−1 (Supporting Information Figure S7).  
4,7-Dichloro-5-fluoro-2,9-dimethyl-1,10-phenanthroline (4h) [44]; beige; 1.4 g (4.6 mmol, 93%); m.pdec. = 
213.0–213.5 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 2.97 (s, 3H, CH3), 3.01 (s, 3H, CH3), 7.67 (s, 1H, 
aromatic), 7.68 (s, 1H, aromatic), 7.86 (d, 3JH,F = 13.1 Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 
MHz) δ = 25.3, 25.5, 105.6 (d, 2JC,F = 26.0 Hz), 118.0 (d, 3JC,F = 12.5 Hz), 125.1 (d, 3JC,F = 11.1 Hz), 126.1 (d, 
1JC,F = 184.1 Hz), 140.3, 142.8 (d, 2JC,F = 68.6 Hz), 147.0, 154.9, 157.5, 159.1, 161.3; 19F{1H}-NMR (CDCl3; 
470.5 MHz) δ = −110.97; 19F-NMR (CDCl3; 470.5 MHz) δ = −110.97 (d, 3JF,H = 11.5 Hz); GC-MS: tr = 8.2 
min, (EI) M+ = 294 (100%), 296. (64%), [M-Cl]+ = 259 (12%); Anal. Calcd for C14H9N2Cl2F: C, 56.97; H, 
3.07; N, 9.49; Found: C, 56.90; H, 3.19; N, 9.32; UV-Vis (methanol; λ [nm] (logε)): 309 (3.88), 296 (3.95), 
273 (4.46), 241 (4.47), 211 (4.40); IR (KBr): ν̃ = 3471, 3075, 1628, 1579, 1375, 1145, 858 cm−1 (Supporting 
Information Figure S8).  
4,5,7-Trichloro-2,9-dimethyl-1,10-phenanthroline (4i); beige; 1.2 g (3.9 mmol, 78%); m.pdec. = 162.9–163.7 
°C; 1H-NMR (CDCl3; 400.2 MHz) δ = 2.92 (s, 3H, CH3), 2.94 (s, 3H, CH3), 7.63 (s, 1H, aromatic), 7.66 (s, 
1H, aromatic), 8.27 (s, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 25.3, 25.7, 122.7, 124.5, 
124.6, 125.0, 128.0, 129.0, 142.1, 142.3, 144.8, 147.6, 160.2, 160.3; GC-MS: tr = 9.9 min, (EI) M+ = 310 
(100%), 312 (95%), [M-Cl]+ = 275 (11%), [M-2Cl]+ = 240 (40%); Anal. Calcd for C14H9N2Cl3: C, 53.97; H, 
2.91; N, 8.99; Found: C, 53.90; H, 3.01; N, 8.87; UV-Vis (methanol; λ [nm] (logε)): 316 (4.16), 304 (4.21), 
274 (4.64), 247 (4.67), 210 (4.55); IR (KBr): ν̃ = 3456, 3065, 2922, 1594, 1576, 1528, 1332, 905, 874 cm−1 
(Supporting Information Figure S9).  
5-Bromo-4,7-dichloro-2,9-dimethyl-1,10-phenanthroline (4j); beige; 1.2 g (3.4 mmol, 68%); m.pdec. = 180.1–
181.7 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 2.93 (s, 3H, CH3), 2.95 (s, 3H, CH3), 7.63 (s, 1H, aromatic), 
7.69 (s, 1H, aromatic), 8.58 (s, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 25.2, 25.8, 116.2, 
123.2, 125.0, 125.1, 127.8, 129.2, 142.1, 143.0, 145.0, 147.2, 160.0, 160.5; GC-MS: tr = 12.5 min, (EI) M+ = 
354 (63.7%), 356 (100%), 358 (44%), [M-Br]+ = 275 (28%); Anal. Calcd for C14H9N2Cl2Br: C, 47.23; H, 
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2.55; N, 7.87; Found: C, 47.90; H, 2.67; N, 7.86; UV-Vis (methanol; λ [nm] (logε)): 318 (3.97), 306 (4.02), 
275 (4.43), 249 (4.43), 213 (4.34); IR (KBr): ν̃ = 3452, 2923, 1588, 1438, 1117, 900, 876, 718 cm−1 
(Supporting Information Figure S10).  
4,7-Dichloro-2,5,9-trimethyl-1,10-phenanthroline (4k) [42,44]; beige; 1.2 g (4.3 mmol, 86%); m.p. = 111.9–
112.6 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 2.92 (s, 3H, CH3), 2.96 (s, 3H, CH3), 3.11 (s, 3H, CH3), 7.62 
(bs, 2H, aromatic), 7.95 (s, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 25.2, 25.6, 26.3, 123.9, 
124.5, 124.6, 125.4, 126.9, 133.8, 142.3, 143.1, 144.9, 147.2, 159.0, 159.1; CP/MAS 13C-NMR δ = 25.0, 27.5, 
122.5, 123.5, 131.0, 139.0, 143.3, 145.3, 158.3; CP MAS 15N-NMR δ = −75.52; GC-MS: tr = 9.7 min, (EI) 
M+ = 290 (100 %), [M-Cl]+ = 255 (12%); Anal. Calcd for C15H12N2Cl2: C, 61.88; H, 4.15; N, 9.62; Found: 
C, 61.89; H, 4.20; N, 9.60; UV-Vis (methanol; λ [nm] (logε)): 343 (3.57), 311 (3.73), 275 (4.30), 254 (4.34), 
213 (4.24); IR (KBr): ν̃ = 3452, 2924, 1609, 1579, 1530, 1439, 1380, 1236, 902, 871, 716 cm−1 (Supporting 
Information Figure S11).  
4,7-Dichloro-2,9-dimethyl-1,10-phenanthroline-5-carbonitrile (4l); beige; 0.5 g (1.6 mmol, 32%); m.pdec. = 
188.6–189.9 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 2.96 (s, 3H, CH3), 2.99 (s, 3H, CH3), 7.72 (s, 1H, 
aromatic), 7.73 (s, 1H, aromatic), 8.79 (s, 1H, aromatic); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 25.6, 
26.2, 106.9, 118.4, 122.6, 123.7, 125.6, 127.0, 134.3, 142.2, 143.7, 146.1, 146.8, 161.6, 163.8; GC-MS: tr = 
10.5 min, (EI) M+ = 301 (100%), [M-Cl]+ = 266 (14%); Anal. Calcd for C15H9N3Cl2: C, 59.63; H, 3.00; N, 
13.91; Found: C, 59.89; H, 3.27; N, 13.87; UV-Vis (methanol; λ [nm] (logε)): 353 (3.07), 337 (3.68), 319 
(4.24), 307 (4.31), 275 (4.67), 249 (4.60), 235 (4.54), 211 (4.59); IR (KBr): ν̃ = 3471, 3406, 2223, 1587, 1443, 
1357, 1338, 908, 847 cm−1 (Supporting Information Figure S12).  
Ethyl 4,7-dichloro-2,9-dimethyl-1,10-phenanthroline-5-carboxylate (4m); beige; 0.7 g (1.9 mmol, 38%); m.p. 
= 115.9–116.2 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.43 (t, 3JH,H = 7.1 Hz, 3H, OCH2CH3), 2.93 (s, 3H, 
CH3), 2.94 (s, 3H, CH3), 4.49 (q, 3JH,H = 7.1 Hz, 2H, OCH2), 7.65 (2s, 2H, aromatic), 8.31 (s, 1H, aromatic); 
13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 14.1, 25.5, 25.9, 62.6, 122.1, 123.5, 123.8, 124.9, 126.0, 129.3, 141.7, 
143.6, 146.3, 146.6, 160.5, 161.5, 169.0; GC-MS: tr = 10.9 min, (EI) M+ = 348 (45%), [M-Cl]+ = 313 (21%); 
Anal. Calcd for C17H14N2Cl2O2: C, 58.47; H, 4.04; N, 8.02; Found: C, 58.90; H, 4.25; N, 7.98; UV-Vis 
(methanol; λ [nm] (logε)): 308 (3.88), 295 (3.95), 272 (4.43), 245 (4.44), 212 (4.33); IR (KBr): ν̃ = 3432, 
2980, 1727, 1577, 1275, 1248, 1214,1190, 1122, 1031 cm−1 (Supporting Information Figure S13). 
3.3.4. Hydrolyses of 4e.  
Compound 4e (1.0 g, 3.7 mmol) was dissolved in concentrated hydrochloric acid (35%) (23 mL) 
at r.t. After stirring for 72 h at 100 °C, the volatiles were evaporated. The crude product was purified 
by extraction at Soxhlet apparatus (H2O) and finally was dried over P4O10 to yield a precipitate of 7-
chloropyrrolo [2,3,4-de][1,10]phenanthrolin-5(4H)-one (4f, 0.3 g, 1.4 mmol, 37%). 
3.4. Syntheses of 4,7-di(pyrrolidin-1-yl)-1,10-phenanthrolines 5a, 5b, 5c, 5d and 5e  
These were based on the procedure described in [24]. Our modifications to this procedure involve the 
purification. The appropriate compounds 4a, 4c, 4g, 4h or 4k (1.0 mmol) were mixed with pyrrolidine 
(1.5 g, 21.0 mmol) in a microvave vial equipped with a magnetic stir bar. The vial was sealed, placed 
in a microwave reactor and heated at 130 °C for 45 min (for compound 5a) or 2 h (for compounds 5b, 
5c, 5d, and 5e). The mixture was cooled to r.t., transferred to a round bottom flask (100 mL) and 
evaporated under reduced pressure. The residue has been washed with saturated NaHCO3 (2 × 10 
mL) with stirring, and then with water (2 × 10 mL). The organic residue has been dissolved with 
CH2Cl2 (20 mL), dried over MgSO4 and evaporated under reduced pressure affording the 
corresponding products. Next, the crude products were purified by chromatography on silica gel 
using methanol/dichloromethane as eluent and finally crystallization from CH2Cl2 to yield 
precipitates as follows: 
4,7-Di(pyrrolidin-1-yl)-1,10-phenanthroline (5a) [24,46]; 0.1 g (0.4 mmol, 38%); m.pdec. = 246.8–247.7 °C; 
1H-NMR (CDCl3; 400.2 MHz) δ = 2.03 (m, 8H, 4CH2), 3.67 (m, 8H, 4CH2), 6.69 (d, 3JH,H = 5.5 Hz, 2H, 
aromatic), 7.93 (s, 2H, aromatic), 8.72 (d, 3JH,H = 5.4 Hz, 2H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 
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MHz) δ = 26.1, 52.4, 105.6, 119.5, 119.6, 148.5, 149.4, 152.9; MS-IT-TOF [M+H]+ = 319 (100%), HRMS (IT 
TOF): m/z Calcd for C20H23N4 [M+H]+ = 319.1917, Found 319.1916; UV-Vis (methanol; λ [nm] (logε)): 
362 (4.26), 328 (4.18), 274 (4.48), 255 (4.43), 217 (4.54); IR (ATR): ν̃ = 2952, 2935, 2860, 1662, 1615, 1552, 
1434,1349, 791, 729 cm−1; (Supporting Information Figure S14).  
5-Chloro-4,7-di(pyrrolidin-1-yl)-1,10-phenanthroline (5b); 0.1 g (0.4 mmol, 42%); m.p. = 151.0–151.6 °C; 
1H-NMR (CDCl3; 400.2 MHz) δ = 1.99 (m, 4H, 2CH2), 2.07 (m, 4H, 2CH2), 3.53 (m, 4H, 2CH2), 3.70 (m, 
4H, 2CH2), 6.67 (d, 3JH,H = 5.8 Hz, 1H, aromatic), 6.90 (d, 3JH,H = 5.6 Hz, 1H, aromatic), 7.92 (s, 1H, 
aromatic), 8.73 (d, 3JH,H = 5.7 Hz, 1H, aromatic), 8.74 (d, 3JH,H = 5.7 Hz, 1H, aromatic); 13C{1H}-NMR 
(CDCl3; 100.5 MHz) δ = 25.1, 26.1, 52.1, 52.4, 105.9, 107.9, 117.7, 118.5, 122.4, 124.1, 145.2, 147.7, 148.2, 
148.9, 152.7, 153.9; MS-IT-TOF [M+H]+ = 353 (100%), HRMS (IT TOF): m/z Calcd for C20H22ClN4 [M + 
H]+ = 353.1527, Found 353.1526; UV-Vis (methanol; λ [nm] (logε)): 372 (3.98), 333 (3.88), 281 (4.22), 262 
(4.19), 220 (4.65); IR (KBr): ν̃ = 2956, 2870,1572, 1514, 1445, 1350, 803 cm−1; (Supporting Information 
Figure S15).  
2,9-Dimethyl-4,7-di(pyrrolidin-1-yl)-1,10-phenanthroline (5c); 0.2 g (0.5 mmol, 48%); m.p. = 165.8–166.0 
°C; 1H-NMR (CDCl3; 500.18 MHz) δ = 2.04 (m, 8H, 4CH2), 2.77 (s, 6H, 2CH3), 3.68 (m, 8H, 4CH2), 6.61 
(s, 2H, aromatic), 7.90 (s, 2H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 25.8, 26.0, 52.4, 105.7, 
118.2, 119.0, 146.3, 158.4, 157.5; CP/MAS 13C-NMR δ = 26.0, 51.8, 104.7, 117.5, 147.3, 149.6, 154.6; 
CP/MAS 15N-NMR δ = −291.94, −62.66; MS-IT-TOF [M+H]+ = 347 (100%), HRMS (IT TOF): m/z Calcd 
for C22H27N4 [M+H]+ = 347.2230, Found 347.2229; UV-Vis (methanol; λ [nm] (logε)): 387 (3.80), 358 
(4.10), 322 (4.04), 273 (4.34), 245 (4.26), 214 (4.35); IR (ATR): ν̃ = 2954, 2866, 1539, 1423, 1349, 1078, 802 
cm−1; (Supporting Information Figure S16).  
5-Fluoro-2,9-dimethyl-4,7-di(pyrrolidin-1-yl)-1,10-phenanthroline (5d); 0.2 g (0.5 mmol, 51%); m.p. = 
100.9–101.0 °C; 1H-NMR (CDCl3; 500.18 MHz) δ = 1.96 (m, 4H, 2CH2), 2.01 (m, 4H, 2CH2), 2.74 (s, 3H, 
CH3), 2.76 (s, 3H, CH3), 3.47 (m, 4H, 2CH2), 3.61 (m, 4H, 2CH2), 6.58 (s, 1H, aromatic), 6.65 (s, 1H, 
aromatic), 7.45 (d, 3JH,F = 15.5 Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 25.6, 25.6, 25.8, 
25.9, 25.9, 51.7, 51.8, 52.0, 102.9 (d, 1JC,F = 27.1 Hz), 106.1, 109.9 (d, 2JC,F = 16.2 Hz), 117.6 (d, 2JC,F = 10.6 
Hz), 144.5, 148.7 (d, 3JC,F = 4.1 Hz), 152.1 (d, J = 1.0 Hz), 152.3, 152.9 (d, 3JC,F = 4.3 Hz), 154.8, 157.1 (d, 
4JC,F = 1.6 Hz), 158.7; 19F-NMR (CDCl3; 470.5 MHz) δ = −112.29 (d, 3JF,H = 15.5 Hz); 19F{1H}-NMR (CDCl3; 
470.5 MHz) δ = −112.29; MS-IT-TOF [M + H]+ = 365 (100%), HRMS (IT TOF): m/z Calcd for C22H26FN4 
[M + H]+ = 365.2136, Found 365.2135; UV-Vis (methanol; λ [nm] (logε)): 407 (3.91), 359 (4.30), 325 
(4.26), 281 (4.56), 256 (4.46), 221 (4.73); IR (KBr): ν̃ = 2957, 2866, 1564, 1431, 1352, 1090, 820 cm−1; CCDC 
1479401; (Supporting Information Figure S17).  
2,5,9-Trimethyl-4,7-di(pyrrolidin-1-yl)-1,10-phenanthroline (5e); 0.1 g (0.4 mmol, 39%); m.p. = 101.7–102.0 
°C; 1H-NMR (CDCl3; 400.2 MHz) δ = 1.97 (m, 4H, 2CH2), 2.03 (m, 4H, 2CH2), 2.68 (s, 3H, CH3), 2.76 (s, 
3H, CH3), 2.77 (s, 3H, CH3), 3.35 (m, 4H, 2CH2), 3.68 (m, 4H, 2CH2), 6.61 (s, 1H, aromatic), 6.85 (s, 1H, 
aromatic), 7.63 (s, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 21.4, 24.4, 25.6, 25.7, 26.0, 52.0, 
52.3, 105.8, 109.3, 117.9, 120.8, 122.4, 127.4, 145.1, 146.7, 153.2, 155.4, 156.7, 157.5; MS-IT-TOF [M + H]+ 
= 361 (100%), HRMS (IT TOF): m/z Calcd for C23H29N4 [M + H]+ = 361.2386, Found 361.2385; UV-Vis 
(methanol; λ [nm] (logε)): 361 (4.17), 325 (4.15), 285 (4.44), 260 (4.36), 216 (4.54); IR (ATR): ν̃ = 2962, 
2846, 1541, 1424, 1349, 1077, 801 cm−1; (Supporting Information Figure S18). 
3.5. Syntheses of 4,7-di(9H-carbazol-9-yl)-1,10-phenanthrolines 5f, 5g, 5h and 5m  
These were based on the procedure described in the literature [25]. To s suspension of NaH (0.1 g, 
3.94 mmol) in THF (50 mL) 9H-carbazole (0.5 g, 3.01 mmol) was added and stirred until evolution of 
H2 ceased. Reagents were stirred under reflux for 30 min. under argon. Compounds 4a, 4b, 4d or 4e 
(1.50 mmol) was then added to the reaction mixture, which was refluxed overnight. After evaporation 
of the solvent to give a solid, water (20 mL) and chloroform (100 mL) was added. The organic layer 
was separated and the aqueous layer was extracted four times with chloroform. The combined 
organic layers were dried over MgSO4. After solvent evaporating, the crude product was purified by 
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column chromatography on silica gel using methanol/dichloromethane as eluent to afford a white 
powder, and finally crystallization from a mixture of CH2Cl2 and hexane to yield solids as follows: 
4,7-Di(9H-carbazol-9-yl)-1,10-phenanthroline [25] (5f) white 0.7 g (1.29 mmol, 86%); m.pdec. = 275.1–280.0 
°C; 1H-NMR (CDCl3; 500.2 MHz) δ = 7.06 (d, 3JH,H = 7.9 Hz, 4H, aromatic), 7.28–7.36 (m, 10H, aromatic), 
7.85 (d, 3JH,H = 4.7 Hz, 2H, aromatic), 8.15 (d, 3JH,H = 7.2 Hz, 4H, aromatic), 9.49 (d, 3JH,H = 4.7 Hz, 2H, 
aromatic); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 110.1, 120.7, 121.0, 123.0, 124.1, 126.5, 126.7, 141.3, 
143.5, 148.8, 151.6; CP/MAS 13C-NMR δ = 109.4, 120.2, 122.0, 123.6, 124.8, 127.4, 139.4, 141.2, 147.5, 
149.2, 150.3; CP/MAS 15N-NMR δ = −250.68, −73.05; UV-Vis (methanol; λ [nm] (logε)): 353 (3.10), 332 
(3.54), 319 (3.54), 277 (4.03), 268 (4.06), 247 (4.16), 230 (4.50), 210 (4.18); IR (ATR): ν̃ = 3062, 2371, 1448, 
1222, 750, 725 cm−1; (Supporting Information Figure S19).  
4,7-Di(9H-carbazol-9-yl)-5-fluoro-1,10-phenanthroline (5g) 0.4 g (0.81 mmol, 54%); m.pdec. = 184.3–185.0 
°C; 1H-NMR (CDCl3; 400.2 MHz) δ = 7.03 (d, 3JH,F = 12.6 Hz, 1H, aromatic), 7.09 (dd, 3JH,H = 7.7 Hz, 3JH,H 
= 5.2 Hz, 4H, aromatic), 7.30–7.43 (m, 8H, aromatic), 7.91 (dd, 3JH,H = 9.9 Hz, 3JH,H = 4.7 Hz, 2H, 
aromatic), 8.18 (t, 3JH,H = 8.4 Hz, 4H, aromatic), 9.47 (d, 3JH,H = 4.4 Hz, 1H, aromatic), 9.54 (d, 3JH,H = 4.6 
Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 106.5 (d, 1JC,F = 24.7 Hz), 109.4, 110.0, 119.6, 
120.7, 120.8 (d, 4JC,F = 1.0 Hz), 121.0, 121.2, 121.4, 123.6, 124.1 (d, 2JC,F = 17.7 Hz), 125.1, 125.5, 126.56 (d, 
3JC,F = 4.8 Hz), 126.58 (d, 2JC,F = 23.6 Hz), 141.1, 141.6, 141.7 (d, 4JC,F = 1.9 Hz), 143.2 (d, 3JC,F = 6.0 Hz), 
146.1, 150.0 (d, 4JC,F = 2.5 Hz), 150.9, 152.6, 154.2, 156.8; 19F-NMR (CDCl3; 470.5 MHz) δ = −112.43 (d, 
3JF,H = 10.6 Hz); 19F{1H}-NMR (CDCl3; 470.5 MHz) δ = −112.43; MS-IT-TOF [M+H]+ = 529 (100%), HRMS 
(IT TOF): m/z Calcd for C36H22FN4 [M + H]+ = 529.1828, Found 529.1823. UV-Vis (methanol; λ [nm] 
(logε)): 367 (3.14), 329 (3.37), 318 (3.37), 278 (3.88), 256 (3.88), 230 (4.33), 209 (4.08); IR (ATR): ν̃ = 3045, 
3023, 2361, 1445, 1224, 744, 720 cm−1; (Supporting Information Figure S20).  
4,7-Di(9H-carbazol-9-yl)-5-methyl-1,10-phenanthroline (5h) white 0.7 g (1.34 mmol, 89%); m.pdec. > 350 
°C; 1H-NMR (CDCl3; 500.2 MHz) δ = 1.60 (d, 4JH,H = 0.8 Hz, 3H, CH3), 6.93 (d, 3JH,H = 8.1 Hz, 2H, 
aromatic), 7.10 (d, 3JH,H = 8.1 Hz, 2H, aromatic), 7.22 (d, 4JH,H = 1.0 Hz, 1H, aromatic), 7.29-7.40 (m, 8H, 
aromatic), 7.68 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 7.80 (d, 3JH,H = 4.7 Hz, 1H, aromatic), 8.16 (d, 3JH,H = 7.7 
Hz, 2H, aromatic), 8.18 (d, 3JH,H = 8.1 Hz, 2H, aromatic), 9.43 (dd, 3JH,H = 6.9 Hz, 3JH,H = 4.7 Hz, 2H, 
aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 21.1, 109.7, 110.1, 120.70, 120.73, 120.8, 121.0, 123.1, 
123.7, 124.0, 124.5, 125.6, 126.2, 126.5, 126.8, 128.2, 133.6, 141.4, 142.2, 142.4, 143.4, 148.0, 149.7, 150.9, 
151.2; CP/MAS 13C-NMR δ = 23.4, 111.3, 116.6, 120.7, 123.3, 126.7, 128.2, 133.7, 136.6, 142.0, 147.4, 148.5, 
150.3; CP/MAS 15N-NMR δ = −254.60, −249.48, −78.17, −54.38; MS-IT-TOF [M + H]+ = 525 (30%), HRMS 
(IT TOF): m/z Calcd for C37H25N4 [M + H]+ = 525.2001, Found 525.2091; UV-Vis (methanol; λ [nm] 
(logε)): 355 (3.32), 333 (3.83), 319 (3.76), 277 (4.28), 256 (4.25), 245 (4.41), 232 (4.72), 210 (4.38); IR (ATR): 
ν̃ = 3046, 2363, 1449, 1230, 747, 723 cm−1; (Supporting Information Figure S21).  
4,7-Di(9H-carbazol-9-yl)-1,10-phenanthroline-5-carbonitrile (5m) brown 0.7 g (1.29 mmol, 86%); m.pdec. = 
145–147 °C; 1H-NMR (CDCl3; 400.2 MHz) δ = 6.93 (d, 3JH,H = 7.4 Hz, 2H, aromatic), 7.07 (d, 3JH,H = 7.3 
Hz, 2H, aromatic), 7.31-7.43 (m, 8H, aromatic), 7.88 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 7.93 (d, 3JH,H = 4.7 
Hz, 1H, aromatic), 8.05 (s, 1H, aromatic), 8.18 (d, 3JH,H = 7.3 Hz, 4H, aromatic), 9.55 (d, 3JH,H = 4.6 Hz, 
1H, aromatic), 9.60 (d, 3JH,H = 4.7 Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 107.1, 109.2, 
109.6, 115.7, 121.0, 121.1, 121.3, 121.7, 123.8, 124.4, 124.5, 125.2, 125.6, 125.8, 126.6, 126.9, 134.4, 141.2, 
142.3, 143.1, 144.5, 148.8, 149.6, 153.1, 154.7; MS-IT-TOF [M+H]+ = 536 (100%), HRMS (IT TOF): m/z 
Calcd for C37H22N5 [M + H]+ = 536.1875, Found 536.1876; UV-Vis (methanol; λ [nm] (logε)): 368 (3.28), 
323 (3.77), 292 (4.23), 286 (4.22), 257 (4.33), 232 (4.73); IR (ATR): ν̃ = 3050, 2925, 2224, 1450, 1226, 752, 
726 cm−1. (Supporting Information Figure S26). 
3.6. Syntheses of 4,7-di(10H-phenothiazin-10-yl)-1,10-phenanthrolines 5i, 5j, 5k and 5n 
To the suspension of NaH (1.1 g, 48.1 mmol) in THF (50 mL) 10H-phenothiazine (8.0 g, 40.0 
mmol) was added and stirred until evolution of H2 ceased. Reagents were stirred under reflux for 30 
min. under argon. Then compounds 4a, 4b, 4d or 4e (20.0 mmol) were added to the reaction mixture 
in one portion. After heating under reflux for 24 h, the solvent was evaporated and a mixture 
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composed of CH2Cl2 (20 mL) and water (20 mL) was added. The organic layer was separated and the 
aqueous layer was extracted four times with chloroform (4 × 20 mL). The combined organic layers 
were dried over MgSO4, and the crude product was purified by crystallization from mixture of THF 
(CH2Cl2) and hexane to yield solid as follows: 
4,7-Di(10H-phenothiazin-10-yl)-1,10-phenanthroline (5i) greenish 10.8 g (18.8 mmol, 94%); m.pdec. = 
149.4–150.0 °C; 1H-NMR (CDCl3; 500.2 MHz) δ = 6.10 (dd, 3JH,H = 8.2 Hz, 4JH,H = 1.1 Hz, 4H, aromatic), 
6.76 (dt, 3JH,H = 7.8 Hz, 4JH,H = 1.6 Hz, 4H, aromatic), 6.82 (td, 3JH,H = 7.5 Hz, 4JH,H = 1.2 Hz, 4H, aromatic), 
7.07 (dd, 3JH,H = 7.6 Hz, 4JH,H = 1.5 Hz, 4H, aromatic), 7.88 (d, 3JH,H = 4.7 Hz, 2H, aromatic), 8.15 (s, 2H, 
aromatic), 9.50 (d, 3JH,H = 4.7 Hz, 2H, aromatic); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 116.0, 121.1, 
123.4, 123.5, 127.1, 127.3, 128.5, 142.9, 146.5, 149.5, 152.0; MS-IT-TOF [M + H]+ = 575 (100%), HRMS (IT 
TOF): m/z Calcd for C36H23N4S2 [M + H]+ = 575.1364, Found 575.1358. UV-Vis (methanol; λ [nm] (logε)): 
302 (3.56), 270 (4.09), 251 (4.33), 237 (4.21), 228 (4.15), 208 (4.14); IR (ATR): ν̃ = 3055, 2984, 1460, 1305, 
1234, 748, 734, 632 cm−1; (Supporting Information Figure S22).  
5-Fluoro-4,7-di(10H-phenothiazin-10-yl)-1,10-phenanthroline (5j) brown 11.4 g (19.2 mmol, 96%); m.pdec. 
= 186.1–187.0 °C; 1H-NMR (CDCl3; 500.2 MHz) δ = 5.84 (d, 3JH,H = 8.2 Hz, 4JH,H = 0.8 Hz, 2H, aromatic), 
6.17 (d, 3JH,H = 8.1 Hz, 4JH,H = 1.2 Hz, 2H, aromatic), 6.69 (td, 3JH,H = 7.4 Hz, 4JH,H = 1.6 Hz, 2H, aromatic), 
6.75 (td, 3JH,H = 7.5 Hz, 4JH,H = 1.3 Hz, 2H, aromatic), 6.80 (td, 3JH,H = 7.4 Hz, 4JH,H = 1.7 Hz, 2H, aromatic), 
6.85 (td, 3JH,H = 7.4 Hz, 4JH,H = 1.3 Hz, 2H, aromatic), 6.98 (dd, 3JH,H = 7.6 Hz, 4JH,H = 1.5 Hz, 2H, aromatic), 
7.08 (dd, 3JH,H = 7.5 Hz, 4JH,H = 1.6 Hz, 2H, aromatic), 7.82 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 7.87 (d, 3JH,F 
= 12.5 Hz, 1H, aromatic), 7.92 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 9.47 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 
9.52 (d, 3JH,H = 4.6 Hz, 1H, aromatic); 13C{1H}-NMR (CDCl3; 125.78 MHz) δ = 106.5 (d, 3JC,F = 24.7 Hz), 
115.4 (d, 1JC,F = 108.4 Hz), 119.8, 121.4, 122.4 (d, 4JC,F = 13.5 Hz), 123.3 (d, 2JC,F = 91.9 Hz), 127.0 (d, 4JC,F = 
14.5 Hz), 127.3 (d, 3JC,F = 16.0 Hz), 128.2, 128.4 (d, 2JC,F = 66.8 Hz), 142.8 (d, 5JC,F = 11.9 Hz), 144.3, 145.7 
(d, 5JC,F = 5.3 Hz), 147.3, 150.6, 151.1, 153.9, 154.7, 156.8; 19F-NMR (CDCl3; 470.5 MHz) δ = −113.33 (d, 
3JF,H = 11.9 Hz); 19F{1H}-NMR (CDCl3; 470.5 MHz) δ = −113.33; MS-IT-TOF [M + Na]+ = 615 (30%), HRMS 
(IT TOF): m/z Calcd for C20H23N4 [M + Na]+ = 615.1089, Found 615.1083. UV-Vis (methanol; λ [nm] 
(logε)): 307 (3.56), 271 (4.04), 250 (4.33), 239 (4.23), 227 (4.14), 210 (4.19); IR (ATR): ν̃ = 3057, 2962, 2360, 
1459, 1312, 1235, 739, 643 cm−1; (Supporting Information Figure S23). 
5-Methyl-4,7-di(10H-phenothiazin-10-yl)-1,10-phenanthroline (5k) purple 9.9 g (16.8 mmol, 84%); m.pdec. 
>350 °C; 1H-NMR (CDCl3; 500.2 MHz) δ = 2.91 (s, 3H, CH3), 5.80 (d, 3JH,H = 8.0 Hz, 2H, aromatic), 6.11 
(d, 3JH,H = 7.9 Hz, 2H, aromatic), 6.65-6.85 (m, 8H, aromatic), 6.96 (d, 3JH,H = 7.3 Hz, 2H, aromatic), 7.07 
(d, 3JH,H = 7.4 Hz, 2H, aromatic), 7.70 (d, 3JH,H = 4.5 Hz, 1H, aromatic), 7.83 (d, 3JH,H = 4.5 Hz, 1H, 
aromatic), 7.92 (s, 1H, aromatic), 9.45 (dd, 3JH,H = 8.4 Hz, 3JH,H = 4.6 Hz, 2H, aromatic); 13C{1H} -
NMR(CDCl3; 100.5 MHz) δ = 23.6, 115.6, 116.0, 119.0, 120.9, 123.0, 123.3, 124.2, 126.8, 127.06, 127.1, 
127.2, 127.8, 129.0, 129.4, 134.5, 142.6, 142.8, 145.4, 146.4, 148.6, 151.0, 151.3, 151.7; CP/MAS 13C-NMR 
δ = 25.9, 116.8, 123.4, 124.6, 127.2, 135.3, 141.5, 144.8, 147.1, 149.0, 152.6, 153.5, 155.6; CP/MAS 15N-
NMR δ = −273.57, −62.21, −51.07; MS-IT-TOF [M + H]+ = 589 (100%), HRMS (IT TOF): m/z Calcd for 
C37H25N4S2 [M + H]+ = 589.15207, Found 589.15059; UV-Vis (methanol; λ [nm] (logε)): 332 (3.28), 307 
(3.79), 273 (4.29), 255 (4.58), 242 (4.48); IR (ATR): ν̃ = 3059, 2960, 1461, 1307, 1241, 736, 631 cm−1; 
(Supporting Information Figure S24).  
4,7-Di(10H-phenothiazin-10-yl)-1,10-phenanthroline-5-carbonitrile (5n) brown 9.9 g (16.6 mmol, 83%); 
m.pdec. = 270–275 °C; 1H-NMR (CDCl3; 500.2 MHz) δ = 5.67 (d, 3JH,H = 8.2 Hz, 2H, aromatic), 6.10 (d, 
3JH,H = 8.1 Hz, 2H, aromatic), 6.67 (t, 3JH,H = 7.8 Hz, 2H, aromatic), 6.77 (t, 3JH,H = 7.4 Hz, 2H, aromatic), 
6.82 (t, 3JH,H = 7.8 Hz, 2H, aromatic), 6.90 (t, 3JH,H = 7.2 Hz, 2H, aromatic), 6.98 (d, 3JH,H = 7.6 Hz, 2H, 
aromatic), 7.13 (d, 3JH,H = 7.6 Hz, 2H, aromatic), 7.89 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 8.01 (d, 3JH,H = 4.6 
Hz, 1H, aromatic), 8.76 (s, 1H, aromatic), 9.58 (d, 3JH,H = 4.6 Hz, 1H, aromatic), 9.65 (d, 3JH,H = 4.6 Hz, 
1H, aromatic); 13C{1H}-NMR(CDCl3; 125.78 MHz) δ = 107.5, 115.1, 115.9, 117.6, 119.6, 121.7, 123.4, 
124.1, 126.9, 127.1, 127.3, 127.7, 128.6, 129.2, 135.0, 142.1, 142.8, 146.4, 147.4, 149.8, 150.7, 154.3, 155.1; 
MS-IT-TOF [M + H]+ = 600 (100%), HRMS (IT TOF): m/z Calcd for C37H22N5S2 [M + H]+ = 600.1317, 
Found 600.1323; UV-Vis (methanol; λ [nm] (logε)): 332 (3.59), 313 (3.79), 298 (3.87), 272 (4.18), 249 
Molecules 2019, 24, 4102 22 of 25 
 
(4.47), 206 (4.35); IR (ATR): ν̃ = 3053, 2926, 2215, 1466, 1313, 1239, 742, 633 cm−1; (Supporting 
Information Figure S25). 
1,10-Phenanthrolin-5-amine (5l) CP/MAS 13C-NMR δ = 101.4, 122.9, 130.5, 132.4, 140.8, 142.9, 145.4, 
146.5, 152.7; CP/MAS 15N NMR δ = −317.08, −78.63, −75.62; (Supporting Information Figure S27). 
3.7. Synthesis of 4,7-di(9H-carbazol-9-yl)-9-oxo-9,10-dihydro-1,10-phenanthroline-5-carbonitrile (6a) and 2-
oxo-4,7-di(10H-phenothiazin-10-yl)-1,2-dihydro-1,10-phenanthroline-5-carbonitrile (6b). 
Compounds 5m or 5n (3.5 mmol) dissolved in a mixture composed of THF and 10% sodium 
hydroxide (55 mL) were stirred for 4 days at 50 °C. The cooled solution was acidified to neutral pH 
with concentrated hydrochloric acid. After solvent evaporation, the crude product was purified by 
column chromatography on silica gel using methanol/dichloromethane as eluent to afford a white 
powder, and finally crystallization from the mixture of CH2Cl2 and hexane to yield solids as follows: 
Compound 6a: yellowish 0.6 g (1.1 mmol, 31%); m.pdec. = 195–200 °C; 1H-NMR (CDCl3; 400.2 MHz) δ 
= 6.90 (d, 3JH,H = 7.3 Hz, 2H, aromatic), 7.14 (s, 1H, aromatic), 7.21 (d, 3JH,H = 8.0 Hz, 2H, aromatic), 7.29–
7.45 (m, 8H, aromatic), 7.65 (s, 1H, aromatic), 7.83 (d, 3JH,H = 4.3 Hz, 1H, aromatic), 8.16–8.17 (m, 4H, 
aromatic), 9.27 (d, 3JH,H = 4.3 Hz, 1H, aromatic), 11.24 (bs, 1H, NH); 13C{1H}-NMR (CDCl3; 100.5 MHz) 
δ = 100.8, 109.1, 110.0, 115.5, 115.7, 121.0, 121.2, 121.5, 121.7, 124.2, 124.4, 124.5, 126.3, 126.7, 126.8, 
126.9, 133.5, 139.0, 140.1, 140.5, 142.2, 143.6, 146.5, 151.8, 161.7; MS-IT-TOF [M + H]+ = 552.1830 (100%), 
[M − H]- = 550.1668 (100%), HRMS (IT TOF): m/z Calcd for C37H22N5O [M + H]+ = 552.1824, Found 
552.1830; UV-Vis (methanol; λ [nm] (logε)): 374 (3.46), 355 (3.57), 329 (3.82), 316 (3.76), 292 (4.27), 287 
(4.25), 282 (4.27), 247 (4.31), 231 (4.62), 210 (4.33); IR (ATR): ν̃ = 3051, 2360, 2218, 1675, 1446, 1226, 747, 
723 cm−1; CCDC 1,917,090 (Supporting Information Figure S28).  
Compound 6b: yellowish 1.0 g (1.6 mmol, 46%); mpdec. = 220–230 °C; 1H-NMR (CDCl3; 400.2 MHz) δ 
= 5.63 (d, 3JH,H = 8.2 Hz, 2H, aromatic), 6.63-6.58 (m, 2H, aromatic), 6.66 (dd, 3JH,H = 7.8 Hz, 4JH,H = 0.9 
Hz, 2H, aromatic), 6.77 (t, 3JH,H = 7.5 Hz, 2H, aromatic), 6.90–7.00 (m, 6H, aromatic), 7.12-7.18 (m, 2H, 
aromatic), 7.25 (s, 1H, aromatic), 7.84 (d, 3JH,H = 4.5 Hz, 1H, aromatic), 8.45 (s, 1H, aromatic), 9.27 (d, 
3JH,H = 4.6 Hz, 1H, aromatic), 11.11 (bs. 1H, NH); 13C{1H}-NMR (CDCl3; 100.5 MHz) δ = 101.0, 115.1, 
116.2, 116.7, 117.5, 119.8, 122.6, 123.5, 124.5, 127.0, 127.2, 127.5, 127.9, 128.5, 129.7, 129.8 134.1, 139.6, 
141.0, 141.9, 142.1, 146.9, 149.2, 153.0, 161.7; MS-IT-TOF [M + H]+ = 616.1271 (100%), [M − H]- = 614.1110 
(100%), HRMS (IT TOF): m/z Calcd for C37H20N5OS [M − H]− = 614.1109, Found 614.1110; UV-Vis 
(methanol; λ [nm] (logε)): 339 (3.94), 295 (4.52), 284 (4.38), 273 (4.18), 251 (4.79), 205 (4.59); IR (ATR): 
ν̃ = 3059, 2974, 2360, 2216, 1673, 1461, 1312, 743, 648 cm−1; CCDC 1,919,692 (Supporting Information 
Figure S29). 
3.8. Electrochemical Setup 
Cyclic voltammetry was measured using a potentiostat PGSTAT12 (Metrohm Autolab B.V., 
Utrecht, The Netherlands) and a three-electrode electrochemical cell with an Ag|AgCl|1M LiCl 
reference electrode separated from the test solution by a salt bridge. A glassy carbon electrode (with 
diameter 0.7 mm) and a platinum wire were the working and counter electrodes, respectively. 
Oxygen was removed from the solution by passing a stream of argon. Stock solution of analyte was 
prepared in degassed anhydrous 99.8% acetonitrile (ACN, anhydrous, Sigma-Aldrich, content of 
water < 0.001%) supplied under argon. Tetrabutylammonium hexafluorophosphate (Sigma Aldrich) 
was used as a supporting electrolyte and dried before use. 
3.9. Molecular Orbital Calculations 
Theoretical calculations of frontier molecular orbital energies were performed using the density 
functional theory (DFT) calculations employing the B3LYP functional and 6-31G* basis set for all 
atoms with Spartan’14, v.1.1.8 software (Wavefunction, Inc., Irvine, CA USA). The spatial distribution 
of HOMO and LUMO orbitals was calculated for the geometry optimized molecules in vacuum. 
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4. Conclusions 
This research has focused on the synthesis of 27 4,7-disubstituted-1,10-phenanthrolines, 
including their 4,7-dichloro-, 4,7-di(9H-carbazol-9-yl)-, 4,7-di(10H-phenothiazin-10-yl)- and 4,7-
di(pyrrolidin-1-yl) derivatives, giving 23 novel compounds. The presented protocols allowed us to 
synthesize the targeted compounds more efficiently, with yields up to 96%. The structures of the 
obtained molecules were proved by a combination of varies techniques, such as NMR, GC-MS, MS, 
HRMS, UV-Vis and X-ray crystallography. A variety of substituents (methyl, halogen (F, Cl and Br), 
CN, 9H-carbazole, pyrrolidine, 10H-phenothiazine, COOEt and COOH groups) were chosen in order 
to represent different electronic features. For the first time 15N CP/MAS-NMR spectra of selected 4,7-
disubstituted-1,10-phenanthroline derivatives were elucidated to differentiate the nitrogen nucleus 
and to give an insight into their characteristics. The electrochemical studies showed the influence of 
substituents on the redox properties of synthesized compounds. Compounds with methyl as R 
substituent were the most difficult ones to reduce. On the contrary, compounds substituted with 9H-
carbazole as R2 had the highest oxidation potentials and were the most stable ones against oxidative 
processes. Compounds substituted with phenothiazine and pyrrolidine as R2 were the most easily 
oxidized due to the oxidation of the substituent R2. Phenothiazine derivatives were also stronger 
electron acceptors and were more facile to reduction than other compounds. Regarding the largest 
potential gap, methylated compounds 4g, 4k and compound 5f containing 9H-carbazole are the most 
stable structures against oxidative and reductive processes. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1. CCDC 1479401 for 5d, 
CCDC 1917090 for 6a and CCDC 1919692 for 6b contains the supplementary crystallographic data for this paper. 
These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the 
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: deposit@ccdc.cam.ac.uk)”. This 
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